Histochemical markers of myelin damage and impaired remyelination in the aging rhesus monkey brain: relationship to cognitive performance by Estrada, Larissa Isabel
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2016
Histochemical markers of myelin
damage and impaired
remyelination in the aging rhesus
monkey brain: relationship to
cognitive performance
https://hdl.handle.net/2144/14608
Boston University
BOSTON UNIVERSITY 
 
SCHOOL OF MEDICINE 
 
 
 
 
 
Dissertation 
 
 
 
 
 
HISTOCHEMICAL MARKERS OF MYELIN DAMAGE AND IMPAIRED 
REMYELINATION IN THE AGING RHESUS MONKEY BRAIN: 
RELATIONSHIP TO COGNITIVE PERFORMANCE 
 
 
by 
 
 
LARISSA ISABEL ESTRADA 
 
B.S., Massachusetts Institute of Technology, 2008 
 
 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Doctor of Philosophy 
 
2016  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2016 
 LARISSA ISABEL ESTRADA 
 All rights reserved  
Approved by 
 
 
 
 
 
First Reader ___________________________________________________ 
 Douglas L. Rosene, Ph.D. 
 Professor of Anatomy & Neurobiology 
 
 
Second Reader ___________________________________________________ 
 Jennifer I. Luebke, Ph.D. 
 Associate Professor of Anatomy & Neurobiology 
 
 
 
  
  
iv
ACKNOWLEDGMENTS 
This work would not have been possible without the assistance and support 
of many people. First, thanks are due to my advisor, Dr. Doug Rosene, for 
encouraging a fun and accepting work environment, providing opportunities to 
develop skills both at and away from the bench, and teaching invaluable lessons. 
I am grateful for the support of my Dissertation Advisory Committee 
members. Committee input was crucial for developing this work into a coherent 
project, and I have learned so much from the critiques and feedback. Dr. Jennifer 
Luebke, thank you for always taking the time to provide detailed feedback, for 
supporting the electron microscopy goals of this work, and for giving key advice at 
several points that helped me find a way forward. Dr. Benjamin Wolozin, thank you 
for serving as the Chairman of both my qualifying and dissertation committees. Dr. 
Tarik Haydar, thank you for giving advice that strengthened some of the weakest 
points in my experimental design, and for being willing to help with the many 
technical issues I encountered along the way. Dr. Ethan Hughes, thank you for 
making the trip to Boston to lend your time and expertise to the final stages of this 
project. 
I’d like to thank past and present members of the “lab family” for their 
companionship, friendship, and support: Dr. Killiany, Dr. Moore, Dr. Moss, Bethany 
Bowley, Penny Schulz, Karen Slater, Becky Smith, Sherri Eldridge, Alana 
Carmichael, Joe Hebert, Dr. Ana Amaral, Dr. Amy Robinson, Carolyn Brown, 
Nadine Heyworth, Eli Shobin, and Mary Orczykowski. Thanks to my trainees 
  
v
throughout the years, in particular Ellen Witkowski and Samantha Calderazzo for 
technical assistance. Thanks to Dr. Farzad Mortazavi and Dr. Maya Medalla for 
giving so much of your time, effort, and patience. Thanks to Dr. Ron Killiany and 
Dr. Howard Cabral for answering my endless questions about statistics. Thanks to 
Dr. Lela Giannaris for being such a dedicated mentor during my first years.  
Thanks to the Pharmacology Department community, in particular the 
Chairman Dr. David Farb, GPN Director Dr. Shelley Russek, Sara Johnson, 
Wanda Roberts, Christina Cherel, Nadiyah Shaheed, Dr. Walsh, Dr. Leeman, Dr. 
Gibbs, and my friends in the student body. 
Thanks to the professors and mentors who helped me gain acceptance into 
graduate school in the first place: Professor Michael Ouellette and Drs. Sinha, 
Gabrieli, Ofen, and Chai. 
Ultimately, I would be nowhere without the constant love and support of 
my family: my parents Walter and Lizzette, my brother Walter J. and sister-in-law 
Samantha, the amazing Ratnayake family, and the patience, love, and positivity 
of my husband Nalin. 
  
  
vi
HISTOCHEMICAL MARKERS OF MYELIN DAMAGE AND IMPAIRED 
REMYELINATION IN THE AGING RHESUS MONKEY BRAIN: 
RELATIONSHIP TO COGNITIVE PERFORMANCE 
LARISSA ISABEL ESTRADA 
Boston University School of Medicine, 2016 
Major Professor:  Douglas L. Rosene, Ph.D., Professor of Anatomy & 
Neurobiology  
 
ABSTRACT 
 Myelin damage is known to increase in the normal aging brain and to 
correlate with age-related cognitive decline. While the causes of increased myelin 
damage are unknown, here we consider whether the brain’s innate capacity for 
remyelination diminishes with age and hence could contribute to myelin damage 
through slow accumulation of myelin defects. Maintenance and repair of myelin 
depends upon oligodendroglia precursor cells (OPCs), which must differentiate 
into a sufficient number of healthy mature oligodendroglia (oligos), the myelinating 
cell of the brain. The extracellular matrix molecule hyaluronic acid (HA) has been 
shown to inhibit maturation of OPCs into mature myelinating oligos. The present 
study examined aging changes in myelination using four markers: the damaged 
myelin basic protein (dMBP) antibody, a histochemical reaction to stain HA, and 
immunohistochemistry for OPCs and mature oligos. These markers were 
quantified using cell density (oligos and OPCs), percent area stained (HA and 
dMBP), and fluorescence intensity (HA and dMBP). Relationships between these 
markers, age, and behavioral measures of cognitive function were investigated 
  
vii
using single and multiple regression analyses. Results showed that in the corpus 
callosum and cingulum bundle of the rhesus monkey, staining for dMBP as a 
marker of myelin damage strongly correlated with increases in HA. The increase 
in HA in the cingulum bundle correlated positively with age. OPC density increased 
with age in both the cingulum bundle and corpus callosum. Mature oligo density 
did not change significantly with age, but approached a significant increase in the 
cingulum and approached a significant decrease in the corpus callosum. The 
increase in OPC density correlated positively with both HA and dMBP in the 
cingulum bundle. These data are consistent with the hypothesis that HA 
accumulation contributes to myelin damage by inhibiting the differentiation of 
OPCs into mature oligodendrocytes, diminishing the brain’s innate capacity for 
remyelination with age. 
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CHAPTER ONE: INTRODUCTION AND SPECIFIC AIMS 
Myelin damage and mild cognitive decline in the normal aging brain 
 Normal aging is associated with impairments in cognitive domains such as 
executive function, learning, and memory, collectively referred to as mild cognitive 
decline (MCD; Herndon et al., 1997; Moss et al., 2007). Unlike in dementias such 
as Alzheimer’s, in the normal aging monkey brain neurons are not lost with age 
(e.g. Tigges et al., 1990; Peters et al., 1998; Roberts et al., 2012; Giannaris & 
Rosene, 2012). While many changes take place in the aging brain (loss of 
synapses, decreased complexity of dendritic arbors, vascular changes; reviewed 
by Luebke et al., 2010 and Kohama et al., 2012), myelin changes are a category 
that correlates with cognitive decline (reviewed by Peters & Rosene, 2003; 
Kohama et al., 2012; Peters & Kemper, 2013). 
Myelin is made of extensions of the cell membrane of mature 
oligodendrocytes (oligos), which wind around a segment of exposed axon and 
compact into a many-layered structure, functioning as electrochemical insulation 
to enable saltatory conduction of action potentials (reviewed by Sherman & 
Brophy, 2005; Aggarwal et al., 2011; Figure 1). The myelin membrane can also 
provide metabolic support to the axon (Lee et al., 2012). Electron micrographs 
showing healthy myelin structure and some pathologies that occur in normal aging 
are shown in Figure 2. 
The myelin pathologies observed in normal aging are seen at levels ranging 
from the ultrastructural (e.g. Bowley et al., 2010; Peters et al. 2002) to whole brain 
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MRI imaging (e.g. Makris et al., 2007; Wisco et al., 2008). At the MRI level there is 
an age-related decrease in MRI volumes but the largest change is in white matter 
(whole brain -5.01%, gray matter -2.08%, and white matter -11.53%; Wisco et al., 
2008). Fractional anisotropy (FA), a diffusion tensor imaging (DTI) measure of the 
degree to which water movement is constrained, is regarded as a marker of myelin 
sheath integrity and reductions in FA as markers of myelin damage (reviewed by 
Beaulieu, 2002). DTI scans of the aging monkey brain have shown decreases in 
FA in the superior longitudinal fasciculus, anterior corpus callosum, and cingulum 
bundle, each of which correlated significantly with decline in performance learning 
a test of executive function (Makris et al., 2007).  
Ultrastructural evidence of myelin damage in aging rhesus monkeys has 
been observed using electron microscopy by Peters and colleagues (Feldman & 
Peters, 1998; Sandell & Peters 2002 and 2003; Peters et al., 2000, 2002, 2010). 
These investigators reported myelin pathologies that include splitting of the major 
dense line, splitting of the intraperiod line, ballooning myelin sheaths, double 
sheaths (split circumferentially around the axon), and “redundant” sheaths (in 
which loops of excess myelin wind far to the side of the axon) in both white matter 
and cortical areas of the brain. Examples of these pathologies are shown in Figure 
2. Areas that contain such damage include prefrontal area 46 and corpus callosum 
(Peters & Sethares, 2002), area 17 (Peters et al., 2000), the optic nerve (Sandell 
& Peters, 2002), the anterior commissure (Sandell & Peters, 2003), and the fornix 
(Peters et al., 2010). These myelin pathologies increase with age, and sometimes 
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loss and/or degeneration of axons is also observed. For instance, in the cingulum 
the myelin damage is accompanied by loss of axons, and myelin sheath alterations 
correlate with increased impairment in several cognitive tests (Bowley et al., 2010). 
Some ultrastructural changes in the aged rhesus monkey brain have been 
regarded as evidence that remyelination occurs in adulthood. Aged monkeys have 
some sheaths that are too thin for the diameter of the axon they surround, which 
is classically interpreted as a sign of ongoing remyelination (Peters & Sethares, 
2003) but could also signify that remyelination occurs more slowly or incompletely 
in the aged brain. Redundant and double sheaths occur in the aged but not young 
brain, an indication that new myelin in aged brains may not always form properly 
(Peters & Sethares, 2003). Aged monkeys have shorter myelin internodes and an 
increased frequency of paranodes, also considered a sign of remyelination (Peters 
& Sethares, 2003). The increased frequency of paranodes in Area 46 correlates 
with cognitive decline (Peters & Sethares, 2003). 
To interpret signs of remyelination in aged brains, it is important to first 
understand the mechanisms of myelin formation in development, myelin 
maintenance and “myelin plasticity” in the healthy adult brain, and remyelination in 
injury and disease. These topics are reviewed below. 
Timeline and mechanics of initial myelination 
The timing and structural logistics of myelin formation are tightly regulated 
by both intrinsic and microenvironmental factors (reviewed by Mitew et al., 2014). 
Myelination in the CNS is performed by newly generated oligos (e.g. Rivers et al., 
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2008; Koenning et al., 2012), which differentiate from oligodendroglia precursor 
cells (OPCs; Watanabe et al., 2002). The new oligos are first in a “premyelinating” 
stage in which they lose expression of the OPC marker PDGF receptor alpha (Butt 
et al., 1997), and begin extending many membrane processes, but do not yet 
contact axons. In response to growth factors and neural activity (reviewed by Mitew 
et al., 2014), each premyelinating process can contact one or more axons (Back 
et al., 2002b) and begin ensheathment. After initial ensheathment, MBP is 
transported into the processes and myelin compaction begins to produce the 
mature myelin structure (Back et al., 2002b; Aggarwal, 2013). 
Many of the structural properties of myelin are derived from the molecular 
properties of MBP. MBP has electrostatic, pH-driven interactions with the oligo 
plasma membrane, as well as interactions with the hydrophobic, phenylalanine-
rich domains on other MBP molecules. These properties enable MBP to function 
like a zipper, fusing the two leaflets of the oligo membrane together, excluding 
most other membrane-bound proteins (based on size), and squeezing out 
cytoplasmic material (Aggarwal et al., 2013). The compressed cytoplasm forms an 
electron dense line when observed by electron microscopy, and is thus referred to 
as the major dense line. The compressed space between layers of membrane, 
which is continuous with the extracellular space, is referred to as the intraperiod 
line. One longitudinal segment of myelin is referred to as an internode, and an axon 
is ensheathed by many internodes along its length. The unmyelinated space 
between internodes, at which receptors and ion channels are clustered for the 
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saltatory propagation of action potentials, is called the Node of Ranvier. The area 
between the node and the internode, at which the myelin sheath becomes 
progressively thinner through a spiraling decrease in number of wrapped layers, is 
referred to as the paranode. 
In rodents and zebrafish, premyelinating oligos have a short window of time 
in which they are able to extend premyelinating processes—after this window, the 
number of processes cannot increase, and can decrease only if they are not 
successful in contacting an axon (reviewed by Mitew et al., 2014). This window of 
time was approximately 5 hours in live zebrafish (Czopka et al., 2013) and 12 hours 
in rodent-derived cell culture lines (Watkins et al., 2008). Premyelinating oligos that 
are unable to myelinate undergo apoptosis (Trapp et al., 1997). 
There is some evidence that premyelinating oligodendrocytes in developing 
humans may have a more flexible window of time in which they are capable of 
initiating myelination (Back et al., 2002b). A study that examined oligo lineage cells 
in parietal lobe white matter of human embryos (Back et al., 2002b) found that the 
first premyelinating oligos (identified by the O4 immunohistochemical marker) 
appeared at around 18 weeks post-conception, but myelination was not seen until 
post-conceptional week 30. However, as this was a cross-sectional study, the 
authors did not directly demonstrate that the same oligos present at week 18 
survived to perform myelination at week 30. 
The myelination process is regulated by both pro-myelination and inhibitory 
signals to ensure that only the correct axons are myelinated, and that each sheath 
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reaches an appropriate final thickness for its diameter (reviewed by Mitew et al., 
2014). Interestingly, MBP has many splice forms and post-translational 
modifications (Harauz et al., 2009) and some forms signal actively in the nucleus 
(Pedraza et al., 1997). 
The gene called myelin gene regulatory factor (MRF or MYRF) encodes a 
transcription factor that functions as a genetic switch for the expression of myelin-
related genes (Emery et al., 2009; Koenning et al., 2012; Bujalka et al., 2013). 
Expression of this gene is required for myelination to occur—if knocked out, oligos 
undergo apoptosis (Emery et al. 2009). If knocked out in oligo-lineage cells once 
mice reach adulthood, the mice demyelinate after a delay of approximately 5 
weeks, with symptoms of demyelination peaking around 8 weeks (Koenning et al., 
2012), indicating that continued expression of MRF is required for healthy myelin 
maintenance in the adult brain, and supporting other evidence (e.g. Lajtha et al., 
1977; Kramer et al., 2001; Ando et al., 2003) that myelin components continually 
undergo turnover in the adult. 
Myelin maintenance in the healthy adult brain 
Myelin is a dynamic structure, continually undergoing structural 
modifications and repair. As reviewed by Wang and Young (2014) there are three 
types of myelin plasticity: 1) myelination of previously unmyelinated axons to speed 
their rate of action potential propagation; 2) repair or replacement of damaged 
myelin to maintain its functionality; and 3) “myelin remodeling,” the phenomenon 
in which newly generated oligos insert new internodes between pre-existing ones 
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on axons with intact myelin (Young et al., 2013). Although this remodeling would 
theoretically slow action potential conduction somewhat, it could actually serve to 
fine-tune the timing and synchronicity of circuits within the brain (Pajevic et al., 
2014). 
While the process of myelinating previously unmyelinated axons begins 
early in life, some white matter structures contain a relatively large proportion of 
unmyelinated axons even in the adult. For example, developmental myelination is 
mostly complete in the mouse at 8 weeks of age (Agrawal et al. 2009), but at this 
time point the mouse corpus callosum still contains more than 70% unmyelinated 
axons, as opposed to the mouse optic nerve, in which nearly all of the axons are 
myelinated (discussed by Young et al., 2013). In humans, frontal white matter 
structures are the last to undergo substantial de novo myelination, and white 
matter volume continues to increase into adulthood as shown by imaging (Giedd 
et al., 2015) and into the late 30s as shown by histochemistry (Miller et al., 2012). 
The myelination of previously unmyelinated axons is considered a form of “myelin 
plasticity” because it is a means by which signaling can be altered, sometimes in 
response to activity (reviewed by Wang & Young, 2014).  
The phenomenon known as “myelin remodeling” demonstrates that 
mechanisms exist to control not only whether or not an axon is myelinated, but to 
what degree it is myelinated. The incorporation of additional myelin internodes onto 
already myelinated axons could serve to fine-tune the timing of signals in neural 
circuits with experience in adulthood (Young et al., 2013; Pajevik et al., 2014; 
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reviewed by Wang & Young, 2014), providing an additional explanation for why 
continuing myelination later into adulthood would confer a functional advantage. 
For example, it has been demonstrated that myelination in humans continues into 
later stages of adulthood than even chimpanzees (Miller et al., 2012).  
In addition to adding new myelin sheaths, the components within myelin 
also undergo turnover in the adult brain. Using a radioactive tyrosine marker in 
adult male mice, Lajtha and colleagues (Lajtha et al., 1977) estimated that one-
fifth of proteins in myelin were replaced over a ten day period. The lipid 
components of adult mouse myelin also turn over, though more slowly than the 
proteins (Ando et al., 2003). Additionally, the rate of lipid turnover was reported to 
increase in aged mice relative to young adult mice (Ando et al., 2003). This shows 
that myelin repair and maintenance occur not only on the level of replacing 
damaged internodes, but also refreshing the chemical material of the myelin itself. 
Since many materials for myelin maintenance are trafficked from the oligo soma 
(Kramer et al., 2001), oligos likely have to expend considerable energy maintaining 
the structural integrity of their extensive myelin membranes, even after the initial 
formation of myelin segments. 
Remyelination in injury and disease 
Although remyelination and myelin turnover are naturally ongoing 
processes in the healthy brain, much of what is known about myelin dynamics in 
the adult CNS comes from the study of pathological conditions such as multiple 
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sclerosis (MS), the rodent MS model named experimental autoimmune 
encephalomyelitis (EAE), spinal cord injury, and other models of demyelination.  
MS is a condition in which CNS demyelination is mediated by inflammation, 
autoimmunity, and eventually progressive neurodegeneration (reviewed by Trapp 
& Nave, 2008). Pathologically, MS is characterized by areas of demyelination 
referred to as “plaques” in the CNS gray matter and white matter. There is 
considerable variety in any individual’s progression of the disease, but in general 
there are periods of increased severity, alternating with remission of symptoms 
and partial remyelination of plaques (termed “shadow plaques”). Over time, 
remyelination becomes less complete, leading to loss of axons and neurons, and 
eventually cognitive dysfunction in a subset of patients (reviewed by Trapp & Nave, 
2008). The reason for the eventual failure of remyelination is not understood, but 
may be due to one or more of the following: problems with OPC recruitment or 
differentiation, myelin production by mature oligos, damage to the axon caused by 
long-term lack of myelination, and epigenetic changes to oligo lineage cells (Chang 
et al., 2000; Shen et al., 2008; Kuhlmann et al., 2008).  
The study of MS has provided evidence that remyelination occurs in the 
adult brain, though the process may be limited by time and/or the extent of 
damage. For example, OPCs are recruited to MS lesions, but in advanced plaques 
they do not differentiate into mature oligos (Kuhlmann et al., 2008). Hyaluronic acid 
(HA) has been shown to accumulate in demyelinated plaques, and may inhibit 
OPC differentiation (Back et al., 2005; see below). Since MS is a disease that 
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affects patients through multiple decades of adulthood and old age (Rist & 
Franklin, 2008) the study of remyelination in aging will provide information 
important in the development of new MS therapeutics. Enhancing remyelination is 
a promising therapeutic strategy (Chang et al., 2012). 
Another commonly used model of demyelinating disease is the chemical 
demyelination model, in which a chemical demyelinating agent (e.g. lysolecithin, 
ethidium bromide) is injected directly into white matter. While some demyelinating 
chemicals, such as cuprizone, can instead be added to food, controlled injections 
can create nearly identical, highly reproducible lesions, making this technique 
useful for comparisons between regions, individual subjects, and separate studies. 
Spinal cord injury results in mechanical demyelination from the transection 
of axons and their myelin sheaths, as well as inflammatory demyelination in 
response to the tissue damage that must be phagocytosed. In response to the 
tissue damage and compromised blood brain barrier, astrocytes form a “glial scar,” 
a structure composed of compacted astrocyte processes, secreted ECM materials 
such as proteoglycans, and (if the dura mater was penetrated) cells such as 
meningeal fibroblasts (reviewed by Silver & Miller, 2004). The glial scar functions 
as a shield against microbes, toxins, and peripheral immune cells that infiltrate 
when the blood brain barrier is compromised (reviewed by Sofroneiw & Vinters, 
2010), but axons cannot easily cross this barrier, presenting a key problem in the 
study of spinal cord injury (Silver & Miller, 2004).  
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These disease states and models have all yielded invaluable information to 
the study of myelin maintenance and repair. However, the mechanisms of 
demyelination and glial response to damage are different in each condition so it 
cannot be assumed that these mechanisms are also responsible for myelin 
damage in the normal aging brain. For example, OPCs in the injured CNS can 
differentiate into astrocytes (Magnus et al., 2007), in contrast to OPCs in healthy 
post-natal white matter which only differentiate into oligos (Watanabe et al., 2002). 
The ability of OPCs in the injured brain to produce astrocytes is presumably due 
to the demand for astrocytes in order to form the glial scar, but remyelination 
capacity may be affected if OPCs preferentially produce astrocytes over oligos. It 
is not known whether the pathologies that occur with normal aging result in OPC 
function that is more similar to the healthy adult brain or a disease state. For 
instance, it could be the case that the astrogliosis that occurs in the aged brain 
(Sloane et al., 2000) creates a similar demand for astrocytes and induces OPCs 
to differentiate into astrocytes as well as oligos. While this key question remains 
unanswered, implications of spinal cord injury studies for the aging brain can only 
be inferred with caution. 
Collectively, studies of remyelination in injury and disease reinforce the 
concepts that: 1) adult white matter has regenerative capacity; 2) this capacity is 
limited; and 3) the source of the limitations, and the reasons why the limitations 
increase over time and/or use, are still unknown. 
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Remyelination in the aged brain 
Although the adult brain has the ability to remyelinate, there is nevertheless 
accumulating myelin damage with aging. This could be because remyelination 
processes are intact but are of insufficient speed or scale to repair a faster rate of 
damage, or because remyelination itself is impaired with age. An experiment by 
Sim and colleagues (2002) using chemical demyelination in the caudal cerebellar 
peduncle of the rat found that remyelination was impaired in aged subjects, and 
that the impairment was due to changes in both the migratory and proliferative 
capacity of OPCs with age. This experiment used only female rats, and to this point 
a study by Li and colleagues (Li et al., 2006) found that remyelination in aged 
animals was sex-dependent. They found that after creating a chemical 
demyelination lesion, young male and female rats remyelinated equally, but aged 
female rats remyelinated more completely at the same time point than aged males. 
Interestingly, Li and colleagues (Li et al., 2006) showed that the difference between 
aged males and females persisted even when the rats were 
castrated/ovariectomized (and young rats still had equal remyelination capacity 
when castrated/ovariectomized), but a study using 6 month old mice showed that 
castration produced a female phenotype of oligodendrogliogenesis rate (Cerghet 
et al., 2006). Together these data imply that some, but possibly not all, aspects of 
remyelination are affected by androgen levels, and that this hormonal influence 
may also be affected by aging. 
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In aged monkeys, it is unknown whether the increased number of shorter 
internodes reported by Peters and Sethares (Peters & Sethares, 2003) is an 
example of “myelin remodeling” or simply replacement of damaged internodes. 
However the fact that this change correlates with cognitive decline may indicate 
that the new myelin is inadequate to preserve the axons’ original functionality. 
Even though altered myelin sheath structure and the increased frequency 
of paranodes suggest that remyelination occurs in the adult monkey brain, myelin 
damage still accumulates. Since remyelination is performed by newly generated 
oligos (e.g. Koenning et al., 2008; Rivers et al., 2008), any factor in the aging brain 
that affects OPC proliferation, recruitment, or differentiation into mature oligos 
could adversely affect myelin repair and contribute to the accumulation of 
damaged myelin. 
Evidence of hyaluronic acid mediated inhibition of remyelination 
The extracellular matrix molecule hyaluronic acid (HA) is an extracellular 
glycosaminoglycan that forms a branching scaffold structure to which other neural 
extracellular matrix components attach (Scott et al.,1991; reviewed by Sherman & 
Back 2008; reviewed by Bignami et al., 1993). HA also plays active signaling roles 
in the CNS, including guiding cell and axon migration during development 
(reviewed by Sherman & Back, 2008), modulating dendritic voltage-gated calcium 
channels in the hippocampus (Kochlamazashvili et al., 2010), and acting as a 
damage associated molecular pattern (DAMP) that signals through pattern 
recognition receptors on a variety of cell types when tissue damage has occurred 
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(reviewed by Schaefer 2014). Importantly, HA also influences differentiation of 
precursor cells (reviewed by Sherman & Back, 2008). 
Accumulation of HA has been shown to impair the differentiation of 
oligodendroglia precursor cells (OPCs) into mature oligos in a number of myelin 
damage models. Demyelination induced by lysolecithin injection remyelinates 
significantly more slowly if HA is co-injected with the lysolecithin (Back et al., 2005; 
Sloane et al., 2010). In vitro, HA inhibits the differentiation of OPCs into mature 
oligodendroglia through MyD88-mediated TLR2 signaling (Sloane et al., 2010). 
Hyaluronidase digestion of HA in astrocyte-OPC co-cultures leads to increased 
OPC differentiation into mature oligodendroglia, whereas the addition of 
exogenous HA to OPC cultures inhibits differentiation (Back et al., 2005). 
Age-related accumulation of hyaluronic acid in the prefrontal cortex 
HA levels, as measured by an ELISA-based assay, have also been reported 
to increase with age in the prefrontal cortex of rhesus monkeys (Cargill et al., 
2012). In prefrontal cortex gray matter, HA levels ranged from approximately 20-
90 ng/mg of tissue, increasing linearly with age (Cargill et al., 2012). The same 
study reported HA levels ranging from approximately 60-230 ng/mg in white 
matter, but no correlation with age (Cargill et al., 2012). The increase in HA in gray 
matter was attributed to increased transcription of HA synthase 1 by astrocytes, 
and not to changes in HA synthases 2 or 3, nor hyaluronidases HYAL1, HYAL2, 
or HYAL3.  
  
15
While the Cargill study provides useful information, it was limited in several 
key ways. First, for the immunohistochemical portion of their study, the rhesus 
macaques considered “young” ranged in age from 1-4 years old (N=5), which 
corresponds to an age range of 3-12 human years. Those monkeys were not yet 
young adults, and thus a comparison with aged adult monkeys (22-30 years old, 
roughly equivalent to 66-90 year old humans; N=5) confounds early development 
with normal aging, especially because myelination of the frontal lobes continues 
into early adulthood (Giedd et al., 2015). For the biochemical assays, the age 
range for young animals was 1-8 years. Corresponding to a human age range of 
3-24 years old, this cohort similarly included monkeys that were too young for a 
study of adult myelination in normal aging. Secondly, the authors did not define the 
anatomical regions sampled for the HA portion of the study, especially for the white 
matter. Presumably the white matter samples they referred to were from a white 
matter region adjacent to area 46, but they did not specify further (e.g. the dorsal 
portion of the superior longitudinal fasciculus versus subcortical white matter of 
ventral area 46). Lastly, while Cargill and colleagues measured an increase in HA 
using an ELISA-based assay (on gray matter and white matter samples that were 
not anatomically defined), their methods for localizing the increase in HA were 
qualitative, and the methods used for counting cells of the oligodendroglia lineage 
were not based on unbiased counting principles.  
The present study also aimed to investigate whether HA increases in the 
aging forebrain, but compared to Cargill and colleagues (2012), the present study: 
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1) focused on key white matter regions instead of gray matter, 2) nearly doubled 
the number of subjects and nearly tripled the number of sections per subject, 3) 
used subjects of a more suitable age range for a study of normal aging, 4) used 
behavioral data from these subjects to correlate histological findings with cognitive 
impairment, and 5) used semi-automated, quantitative methods for measuring HA 
staining along with the dMBP marker for myelin damage. In the Cargill study, the 
reported increase in HA (as measured by ELISA) was localized in the tissue by 
observer-defined “high-HA areas” and “low-HA areas.” In the present study, the 
relative amount of HA and its location in the tissue were both analyzed by 
quantifying a histochemical reaction to stain HA. HA levels as measured by this 
histochemical reaction were quantified in two ways, the percent area stained and 
the fluorescence intensity of the stain. 
Hypothesis and specific aims 
Hypothesis: HA histochemistry is positively correlated with increases in 
immunohistochemical markers of myelin damage and impaired remyelination, and 
cognitive impairment.  
To investigate whether HA increases in white matter regions that show 
myelin damage with age, and whether HA levels correlate with markers of myelin 
damage and impaired remyelination, tissue samples from 29 cognitively 
characterized rhesus monkeys which spanned the adult age range from 6 to 30 
years of age were analyzed using histochemical markers of HA and of myelin 
damage. These histological findings could thus be compared with behavioral 
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measures of cognition to determine the relevance of observed changes to 
cognitive decline. 
Before the hypothesis could be tested, two technical questions needed to 
be addressed: 1) The available rhesus monkey brain samples had been stored at 
-80°C for up to a decade, so the suitability of these tissue samples for quantitative 
histochemistry needed to be investigated. 2) Since preliminary studies showed 
unexpected dMBP staining in young monkeys, it was necessary to assess the 
specificity of the dMBP antibody. 
The hypothesis and key technical questions were addressed by the following four 
specific aims: 
Aim 1: To determine whether time in -80°C storage affects the quality of 
cryoprotected tissue sections for quantitative histochemistry using multiple 
regression analyses of eleven quantitative histochemistry measures with the 
frozen storage data from their respective subject cohorts.  
Aim 2: To assess the specificity of the dMBP antibody as a marker for myelin 
damage using immunohistochemical controls and immuno electron microscopy. 
Aim 3: To determine whether a) HA accumulates in regions with known age-
related myelin damage, b) dMBP increases in regions with known age-related 
myelin damage c) HA correlates with dMBP, d) HA or dMBP correlate with 
behavioral measures of cognitive impairment. 
Aim 4: To determine whether a) high-HA areas contain altered densities of 
oligodendrocytes and OPCs relative to low-HA areas, and b) high-dMBP areas 
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contain altered densities of oligodendrocytes and OPCs relative to low-dMBP 
areas. 
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Figure 1: Cartoon of basic myelin structure. 
Myelin is formed from the living membrane of an oligodendroglia. Microtubule-
based transport enables mRNA and ribosomes to move within the oligodendroglia, 
from the nucleus to the paranodal pockets of cytoplasm at the end of the 
oligodendroglia process. Membrane components undergo active, constant 
turnover. Image from Sherman & Brophy, 2005. 
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Figure 2: Examples of healthy myelin ultrastructure versus myelin pathologies in normal aging. 
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Electron micrographs from Bowley et al., 2010. A: Healthy myelin structure from 
the cingulum bundle of a 9-year-old female rhesus monkey. B: Myelin from the 
cingulum bundle of a 24-year-old female rhesus monkey. The myelinated sheaths 
are less densely packed than in the cingulum bundle of the young monkey shown 
in A. Sheaths of the axons labeled 1 and 3 have dense inclusions, and 2 has 
ballooning of the sheath. C: Myelin in the cingulum bundle of an 18.4-year-old 
female rhesus monkey. The sheath around the axon labeled D has split 
circumferentially at a major dense line. The myelin around the axon labeled R is 
“redundant,” because it extends far from the axon it ensheaths. Abbreviations in 
the images: As= astrocytic processes, N= an axon at the level of a node, P= an 
axon at the level of a paranode, U=profile of an unmyelinated axon. Scale bar = 2 
microns in all images. 
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CHAPTER TWO: GENERAL MATERIALS AND METHODS 
Subjects and tissue 
The rhesus monkey model of normal aging 
 The rhesus monkey is an ideal model of normal aging because monkeys 
have the ability to perform on cognitive tests analogous to those used on humans, 
they show age-related impairment of cognitive functions (Herndon et al., 1997), 
and they are not susceptible to neurodegenerative disease (Peters & Rosene, 
2003) which would otherwise confound the study of normal aging. Furthermore, 
rodent white matter is rudimentary compared to that of primates (Preuss, 1995). 
The rodent forebrain is composed of less than 20% myelin, while the primate 
forebrain is nearly 50% myelin (Norton et al., 1981; Schoenemann et al., 2005). 
Unlike primates, rodents do not experience age-related white matter loss 
(reviewed by Wang & Young, 2014). Therefore, while there are valuable studies of 
OPC and oligo dynamics in aging rodent brains, in order to investigate age-related 
cognitive decline relevant to humans these questions must be studied in primate 
brain as well. 
Subjects 
All animal procedures were performed in accordance with the Guide for the 
Care and Use of Laboratory Animals (1996) and NIH guidelines, and were 
approved by the Boston University Institutional Animal Care and Use Committee. 
Monkeys were obtained from the Emory University Yerkes National Primate 
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Research Center (Atlanta, GA), and were housed individually under at 12 hour 
light/dark cycle at the Laboratory Animal Science Center at the Boston University 
School of Medicine. Both the Yerkes National Primate Research Center and the 
Boston University Laboratory Animal Science Center are accredited by the 
Association for the Assessment and Accreditation of Laboratory Animal Care. 
All monkeys underwent a battery of behavioral assessments that included 
tests of rule learning, recognition memory, working memory, spatial memory, 
object recognition, and executive function. Scores from the three tests with the 
highest predictive power were combined into a composite score for cognitive 
impairment, the Cognitive Impairment Index (CII; Herndon et al., 1997). These 
tests are 1) acquisition of the delayed non-match to sample (DNMS) task, which 
assess rule learning; 2) performance on the DNMS task with a 2 minute delay, 
which tests recognition memory; and 3) performance on the delayed response 
span task (DRST-spatial), which assesses spatial memory. These cognitive tests 
provide the basis for investigating the relationship between neuroanatomical 
features of each individual monkey with its cognitive capacity. 
Subjects used for each aim are as follows: 
Subjects for Aim 1: A summary of monkeys used to create the eleven 
datasets analyzed in the evaluation of cryostorage methods is shown in Table 1. 
Some cohorts were used for different IHC labels or analysis measures within the 
same study, and are thus identical. Specifically, all pro-BDNF measures were 
acquired from the same subjects, the NeuN and PV cell counts were acquired from 
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the same cohort, HA and dMBP were processed as a double-label and thus used 
the same subjects, and BrdU and DCX cell counts were acquired from the same 
cohort. Some individual subjects were included in more than one cohort. 
Approximately 58% of monkeys were in two or more cohorts, 19% in three or more 
cohorts, and 3% in four or more cohorts. These percentages do not include the 
direct overlap resulting from two staining measures that used the exact same 
cohort. In other words, if a subject was only included in the NeuN and PV studies 
(which had perfect subject overlap), the subject was considered to have 
participated in one cohort for the sake of the percentages reported above. A 
summary of the antigens studied in the cryostorage study is presented in Table 2. 
Subjects for Aim 2: Subjects for immuno electron microscopy (EM) of the 
dMBP antibody included two young female monkeys (AM299, AM199, ages 8.5 
and 10.6 respectively), one middle aged female monkey (AM278, age 15.3), and 
three old female monkeys (AM177, AM336, and AM196, ages 20.9, 21.1, and 
22.9) respectively). Samples for AM336 were processed specifically for electron 
microscopy and so were of superior quality than those of the other subjects. 
Therefore, EM figures and numerical analyses reported are from AM336 tissue. 
AM336 was only used for EM, and was not included in any of the other experiments 
or analyses. 
Subjects for Aim 3: Subjects used for HA and dMBP fluorescent 
histochemistry were 29 rhesus monkeys, 13 males and 16 females, which spanned 
the entire adult age range (6-30 years old, corresponding to human ages 18-90 
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years; Table 3). Cognitive decline in the rhesus monkey begins around 13 years 
of age and worsens after 20 years of age, corresponding to human ages of 
approximately 39 years and 60 years, respectively. 
Subjects for Aim 4: Subjects for CC1 and PDGFRa double 
immunohistochemistry were the same as those for Aim 3, except for the exclusion 
of one young female subject, AM198, because there was no more tissue from this 
monkey remaining in storage. 
Tissue preparation and storage 
Once behavioral testing was complete, monkeys were tranquilized with 
ketamine hydrochloride (10 mg/mL, intramuscular) and deeply anesthetized with 
sodium pentobarbital (15 mg/kg, intravenous, to effect). A thoracotomy was 
performed, and the monkey was euthanized by exsanguination during transcardial 
perfusion with 4% paraformaldehyde solution in 0.1M phosphate buffer (pH 7.4) at 
37°C. Some subjects were perfused first with 4°C Krebs-Henseleit buffer (pH 7.4, 
consisting of 6.4 mm Na2HPO4, 1.4 mm Na2PO4, 137 mm NaCl, 2.7 mm KCl, 5 
mm glucose, 0.3 mm CaCl2, 1 mm MgCl2; Sigma-Aldrich) before the 
paraformaldehyde perfusion stage. After perfusion, brains were blocked in situ in 
the coronal plane, removed intact, weighed, photographed and post-fixed for less 
than 24 hours (e.g. Giannaris et al., 2012; Ngwenya et al., 2015). They were then 
cryoprotected by immersion in 10% glycerol and 2% DMSO in 0.1M phosphate 
buffer (PB) until the block sank (1-3 days depending on size) and then transferred 
to phosphate buffer with 20% glycerol and 2% DMSO until equilibrated (3-5 days). 
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Blocks were then flash frozen in -75°C isopentane and placed into storage at -
80°C until they could be cut into frozen sections (Rosene et al., 1986).  
 For cutting, the frozen blocks were removed from -80°C storage, affixed to 
a freezing stage of sliding microtome and maintained frozen by being surrounded 
with pulverized dry ice that was re-packed every 15 to 20 minutes as needed. 
Blocks were cut into 10 interrupted series of 30 µm thick frozen sections. As they 
were collected the sections were distributed across 24 vials (polystyrene 
hematology cell counter vials, USA Scientific #9040), with each vial containing 6 
to 8 sections in 15-20mL of 15% glycerol in PB. Sections were allowed to 
equilibrate in the 15% glycerol overnight at 4°C and were then frozen by 
transferring the vials into a -80°C freezer where they were kept until thawed for 
processing. The timeline of tissue acquisition, cryoprotection, and storage is shown 
in Figure 3. 
Regions of interest 
Tissue sections were selected from between the level of the rostral edge of 
the corpus callosum and the level at which the temporal lobe attaches to the rest 
of the cerebrum. Figure 4 shows the planes of section that mark these rostral to 
caudal anatomical bounds. Eight sections from within these bounds were 
processed per subject for Aim 3, and 5-6 sections adjacent to those used in Aim 3 
were processed for Aim 4. The outlines in Figure 4 show the regions of interest 
(ROIs) analyzed within each section. 
  
27
Histochemical staining 
Tissue for each study was “batch processed” by removing from the freezer, 
at the same time, vials containing a series of sections from all the cases to be 
studied. Sections were then thawed by placing the vials in a room temperature 
water bath for about 30 minutes to an hour. Sections were then processed together 
in the same reagents. 
Immunofluorescence and fluorescent histochemistry 
Tissue sections were labeled with two fluorophores: streptavidin-conjugated Alexa 
488 (green), used to label HA, and IgG-conjugated Alexa 568 (red), used to label 
dMBP. Sections were all thawed at the same time and “batch processed”—
subjected to the same conditions, solutions, and timing throughout the protocol. All 
steps were performed on a rocker at room temperature (RT) unless otherwise 
specified. All rinses consisted of three ten-minute incubations in 0.05M potassium 
phosphate buffered saline (KPBS), pH7.3, unless otherwise specified.  
The double label histochemistry procedure was as follows: Sections were 
thawed, rinsed, incubated in blocking solution (10% normal goat serum plus 0.5% 
triton X-100 in KPBS) for one hour, and rinsed once in KPBS for 10 minutes. 
Sections were then incubated in a solution containing both 1:500 biotinylated 
hyaluronic acid binding protein (b-HABP; Millipore) and 1:750 damaged myelin 
basic protein antibody (dMBP; Millipore) diluted in KPBS containing 0.5% triton X-
100. This incubation took place in a microwave (Pelco BioWave Pro 36500 
laboratory microwave system) set for 250 W and 20 mmHg vacuum for 6 minutes 
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(3 minutes in the microwave, followed by 5 minutes on a rocker at RT, and then 3 
minutes in the microwave), and then the incubation continued for 18 hours at 4°C. 
The next day, the sections were rinsed and incubated in a solution containing both 
1:1000 streptavidin-conjugated Alexa 488 (Invitrogen) and 1:500 goat anti-rabbit 
IgG Alexa 568 (Invitrogen) diluted in KPBS with 0.5% triton X-100. This incubation 
took place in the microwave set to 250 W, without vacuum, for 6 minutes (3 min in 
microwave, 5 min on a rocker at RT, 3 min in microwave), followed by two hours 
at RT. Sections were then rinsed, mounted onto gelatin-subbed slides, allowed to 
dry enough to adhere to the slide, and then processed for autofluorescence 
elimination. Mounted sections were submerged in 70% ethanol for 5 min, then 
fresh autofluorescence eliminator reagent (Millipore) for 5 min, then 3 times 1 
minute rinses in 70% ethanol, then coverslipped with antifade PPV aqueous 
mounting medium (Sigma). Coverslipped slides were stored in the dark and 
allowed to dry at RT for 48 hours, then were sealed with nail polish and moved to 
dark storage at 4°C. 
Labeling hyaluronic acid using biotinylated hyaluronic acid binding protein 
Hyaluronic acid binding protein (HABP) is the isolated domain of 
proteoglycans that binds to HA with high specificity and affinity. This protein can 
be biotinylated and used as an HA probe (Ripellino et al., 1985). Staining HA with 
biotinylated HABP has been validated previously by Ripellino and colleagues 
(Ripellino et al., 1985) using preabsorption of the probe by HA oligosaccharides 
and predigestion of tissue by Streptomyces hyaluronidase (an enzyme that 
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specifically degrades HA). In our lab, we confirmed that predigestion of tissue in 
Streptomyces hyaluronidase (100 U/mL in buffer at pH 5.4-6.0 for 30 min at 37°C) 
eliminated HABP staining. Additionally, a control condition in which the HABP 
reagent was omitted did not show staining. 
Exposed encephalitogenic peptide as a marker of myelin damage: Overview of 
the EP and dMBP antibodies 
The damaged myelin basic protein antibody (dMBP) targets an epitope of 
myelin basic protein that is concealed when the protein is intact and exposed when 
it is damaged (Matsuo et al., 1997). This epitope is known as the “encephalitogenic 
peptide” (EP) because, as it is normally hidden from the immune system, it reliably 
induces experimental autoimmune encephalomyelitis when injected into mice (e.g. 
Kibler & Shapira, 1968; Matsuo et al., 1997).  
The specificity of the original EP antibody was determined by the many 
experiments of Matsuo and colleagues (Matsuo et al., 1997 and 1998). Control 
experiments they performed included a preabsorption control, ELISAs, dot blots, 
and comparisons between the EP antibody and commercial antibodies with 
epitopes adjacent to the EP sequence in MBP. The antibodies with epitopes 
adjacent to EP stained all myelin structures in both healthy and MS tissue, but the 
EP antibody stained only a subset of myelin structures. The morphology of the EP-
stained structures was described as “abnormal-appearing,” “misshapen,” and 
“degenerate-appearing” by the authors (Matsuo et al., 1997). 
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Since the creation of the EP antibody by Matsuo and colleagues (Matsuo et 
al., 1997 and 1998), a commercial version (AB5864 or dMBP; Millipore) named the 
dMBP antibody has been used to visualize myelin damage in multiple studies and 
species (Ihara et al., 2010 in human CNS; Yamamoto et al., 2009 in human CNS; 
Wu et al., 2012 in the CNS of aged mice; Shi et al., 2011 in guinea pig CNS; Clark 
et al., 2003 in rat PNS; Liu et al., 2012 in rat PNS). This commercial dMBP antibody 
(AB5864; Millipore) was used in the present study. The immunogen used to make 
the commercial variant is a synthetic peptide corresponding to AA residues 69-86 
of guinea pig MBP—one amino acid residue shorter than the 68-86 of guinea pig 
MBP used by Matsuo and colleagues. The missing residue is not from within the 
7 AA domain that is key for the peptide’s encephalitogenic properties (Matsuo et 
al., 1997); however, to confirm its specificity with the protocols used in our lab, the 
dMBP antibody was tested in three ways: 1) a preabsorption control with the exact 
dMBP peptide, 2) minus-primary control sections processed in parallel with the rest 
of the tissue, and 3) immuno-electron microscopy to determine the structures being 
labeled by the antibody. Methods and results for the preabsorption control and 
electron microscopy pertain to Aim 2 and are presented in Chapter 4. 
Chromogen Immunohistochemistry 
Batch processing methods were used, and all steps were performed on a 
rocker at RT unless otherwise specified. Rinse steps always consisted of three 
washes, 5 minutes each in KPBS. All primary and secondary antibodies were 
diluted in 0.05M KPBS pH 7.3 with 0.4% triton X-100. Sections adjacent to those 
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used for the dMBP/HABP double label were thawed, rinsed, incubated in 3% 
hydrogen peroxide in KPBS to eliminate endogenous peroxidases, rinsed, and 
placed in Super Block reagent (Thermo Scientific) for 30 minutes. Tissue was then 
incubated in anti-PDGFRa antibody (Cell Signaling) diluted 1:500 for 1 hour at RT 
then overnight at 4°C. The next day, sections were rinsed, incubated in secondary 
antibody diluted 1:600 for 1 hour at RT and rinsed. Signal was amplified with a 
Vectastain AB Elite kit for 1 hour, rinsed, and developed in diaminobenzidine 
solution. Tissue was then rinsed, incubated in Super Block for 30 minutes, and 
incubated in the CC1 antibody (Millipore #OP80) diluted 1:500, for 1 hour at RT 
then overnight at 4°C. At the start of day 3, tissue was rinsed, incubated in 
secondary antibody diluted 1:600 for 1 hour at RT, then rinsed, incubated in AB 
Elite solution, rinsed, and developed using Vector SG chromogen solution. 
Sections were rinsed, mounted, dried, cleared, and coverslipped. 
Example staining patterns for the PDGFRa / CC1 double label are shown 
in Figure 5. 
PDGFR as a marker for oligodendroglia precursor cells 
Platelet derived growth factor receptor alpha (PDGFRa) is a receptor for 
PDGF, a growth factor important for OPC proliferation (Pringle et al., 1992; Frost 
et al., 2003). OPCs express PDGFRa on their surface (Hart et al., 1989; Wilson et 
al., 2006), and then quickly downregulate expression of the receptor once they 
begin differentiating into mature oligodendrocytes (Butt et al., 1997). PDGFRa is a 
more specific marker of adult OPCs than NG2, which is also expressed by early 
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oligodendrocyte progenitors (Ness et al., 2005) and OPCs that have already lost 
their PDGFRa+ status, indicating that they have started to mature into oligos 
(Wilson et al., 2006). One of the two polyclonal NG2 antibodies tested by Wilson 
and colleagues (Wilson et al., 2006) labeled a subset of astrocytes in tissue. The 
number or proportion of astrocytes was not quantified, but reported as “not 
extensive” (Wilson et al., 2006). Other studies of NG2 antibodies have reported no 
overlap with astrocyte markers (GFAP, S-100; Nishiyama et al., 1996) or markers 
of immune cells including microglia, monocytes, and macrophages (MHC-II, LCA; 
Chang et al., 2000). NG2 also stains more mature precursors than PDGFRa 
(Wilson et al., 2006), and NG2 overlaps faintly with MBP in a subset of cells (not 
quantified; Nishiyama et al., 1996). A2B5, another common oligo progenitor 
marker, is less optimal than PDGFRa because it can also stain neurons in tissue 
sections (Majocha et al., 1989). 
CC1 as a marker for mature oligodendroglia 
CC1 is an antibody originally created to target adenomatous polyposis coli 
(APC), a tumor suppressor protein (Brakeman et al., 1999). APC is expressed in 
neurons in the adult brain, but antibodies that target the N-terminal segment of 
APC (such as CC1) bind specifically to oligos through interaction with a nonspecific 
antigen unrelated to APC (Brakeman et al., 1999). The CC1 antibody is considered 
an optimal marker for oligos in the adult brain because it targets the soma (making 
it easy to see despite the abundance of oligo processes and myelin in the adult 
brain) and is specific to mature stage oligos (Ness et al., 2005). 
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Microscopy, Image Acquisition, and Staining Quantification 
Acquisition of digital image montages from immunofluorescent tissue sections 
All sections were photographed under identical exposure conditions, set up 
via Surveyor imaging software. Non-ROI areas on sections were used to determine 
the optimal exposure settings, and two settings were used for all sections (an 
optimal exposure for HA, and one for dMBP). Briefly, the region of interest was 
specified to the Surveyor program, and the exposure time and excitation setting 
for the dMBP label was entered. Then a Nikon Eclipse E600 epifluorescent 
microscope with a 20x objective, 100W Mercury bulb (Chiu Technical Corporation), 
Diagnostic Instruments camera, and Prior motorized stage was used to acquire a 
photo montage of tiff images of the entire ROI. The same ROI was imaged again 
using the exposure time and excitation wavelength for the HA label. 
Quantification of oligodendroglia density and oligodendroglia precursor cell 
density 
Stereoinvestigator software (Microbrightfield Inc, Williston VT) with an 
optical fractionator (West et al., 1991) was used to obtain counts of CC1+ and 
PDGFRa+ cells in a random sample of fields within ROIs. Slides were randomized 
and blinded to eliminate experimenter bias. On each section, the regions specified 
in Figure 4 were outlined using a 4x objective on a Nikon Eclipse E600 microscope. 
A grid was laid over the outline, and cells were counted at each counting frame 
using a 40x objective. The total cell count sample for each outlined region was 
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then divided by the area of the sample (the area of one counting frame times the 
number of counting frames) to find the cell density within that ROI for that tissue 
section. This process derived four measurements for each tissue section: 1) CC1 
density in the corpus callosum, 2) CC1 density in the cingulum bundle, 3) PDGFRa 
density in the corpus callosum, and 4) PDGFRa density in the cingulum bundle. 
Since 5-6 sections were analyzed per monkey, these four measurements were 
averaged over all the sections from a given subject to yield the average density for 
each cell type within each ROI. 
ImageJ analysis of fluorescent images: Percent area and fluorescence intensity 
measures 
Images were analyzed using ImageJ software (Version 1.47, 
http://imagej.nih.gov/ij). ROIs analyzed were the corpus callosum (CC) and the 
cingulum bundle (CB) within the anatomical boundaries defined in Figure 4. 
Because all images were acquired using the same exposure and camera settings, 
image processing protocols were designed to detect and analyze the dynamic 
range of pixel intensities present in each image. Briefly, a rectangular sample was 
chosen from the center of the ROI on the mosaic image. Each image was 
processed using two macros (Figure 6), one which measured the percent area 
stained and one which measured fluorescence intensity based on an index 
developed by Yamamoto and colleagues (2009).  
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Percent area 
The percent of pixels that show positive label in a thresholded binary image. 
First, the sample’s color channels were separated (from an RGB image to three 
images, R, G, and B) and only the channel corresponding to the correct label was 
processed further (the R channel for dMBP images and the G for HA images). This 
eliminated a small but potentially significant amount of background (in a test 
sample, there was an average difference of approximately 10% between 
processing the RGB image versus the isolated color channel). The single channel 
8 bit image was inverted (making signal dark and background white), and 
brightness and contrast was adjusted based on the mean and standard deviation 
of the intensity histogram of each image. Brightness and contrast thresholds were 
set such that pixels within three standard deviations of the histogram’s mean were 
included. In other words, for the 0 to 255 range of an 8 bit image, the value equal 
to the image mean minus 3 standard deviations was set as 0, and the mean plus 
three standard deviations was set as 255. Finally, a threshold (the value 
automatically determined by ImageJ) was applied to convert the image to binary, 
and the percent area stained (percent of pixels that were black after thresholding) 
was measured. 
Fluorescence Intensity 
The overall fluorescence intensity of an image was determined based on 
the image’s pixel intensity histogram. While the percent area measure counts each 
pixel as either stained or unstained by analyzing thresholded binary images, the 
intensity measure takes into account how brightly each pixel is stained—higher 
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proportions of brighter pixels produce a higher overall fluorescence intensity value 
for that image. To determine an image’s overall intensity, the image intensity 
histogram (ranging from zero to its maximum value) was divided into six parts 
(Figure 6C). The midpoint value of each part was determined. Then the proportion 
of pixels in each part is multiplied by the midpoint value of that part. The products 
of these six multiplications (e.g. midpoint of part 1 times the proportion of pixels in 
part 1) were then added together to obtain a measure of overall image intensity.  
Percent area measures correlated strongly with fluorescence intensity for 
both HA and dMBP, and in both the CC and CB (Figure 7). Because these 
measures are similar, but the fluorescence intensity takes into account more of the 
original image data, only fluorescence intensity results will be reported in most 
cases. The discussion considers the rare cases in which percent area and 
fluorescence intensity yielded different outcomes. 
Statistics 
Correlation, single regression, and t tests 
Single linear regression and t tests were performed using Prism (GraphPad 
Software, Inc; v5.0). As is standard statistical practice, t tests were one-tailed for 
group comparisons for which there was a hypothesized directionality of the 
outcome (e.g. OPCs were expected to increase with age, so the mean OPC 
density should be higher in the aged group than the young “reference” group). T 
tests were two-tailed for group comparisons for which there was no basis for a 
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hypothesized direction of group difference (e.g. comparisons between males and 
females). 
Multiple regression 
 Statistical Analysis Software (SAS; v9.3) was used to perform multiple linear 
regression using a stepwise approach with alpha =0.05. For stepwise analyses, 
each dependent variable was modeled using several independent variables of 
interest (“predictors”), for instance sex, age, total time frozen (TTF), and relevant 
interaction variables. The SAS regression output lists the p value of each predictor 
in the model. If there were predictors with p values greater than alpha, the predictor 
with the greatest p value was eliminated from the model and the regression was 
run again. This one-by-one elimination of the least significant predictor continued 
until only significant predictors remained. The model that included only significant 
predictors at alpha=0.05 was considered the best model.  
Interaction variables were tested to detect the presence of relevant 
confounding effects between independent variables. For example, testing the 
significance of an “age-total time frozen” interaction variable (created by 
multiplying age times total time frozen for each subject) in a multiple regression 
model would enable detection of the confounding effects that would be present if 
tissue from one age group of monkeys happened to be frozen longer than tissue 
from the other age group. Interaction variables did not reach significance unless 
otherwise noted in the Results text.  
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 The linearity assumption was tested by assessing the significance of 
squared terms in multiple regression models. If an X2 term was a significant 
predictor of the dependent variable, a nonlinear (quadratic) model was used to 
analyze that relationship instead of a linear model. 
Explanation of Output Statistics in Multiple Regression 
Five statistics were used to summarize the results of multiple regression 
analyses: 1) the  estimate, 2) the standardized  estimate, 3) the p value, 4) the 
semi-partial R2, and 5) the overall model R2.  
The  estimate is interpreted as the amount of change in the dependent 
variable for a one-unit increase in the independent variable. For independent 
variables that reached significance, the  estimate is reported with its 95% 
confidence interval. 
The standardized  estimate is derived by converting the  estimate into 
standard deviation units. This statistic is thus interpreted as the amount of change 
in the dependent variable for a one standard deviation change in the independent 
variable. While the non-standardized  estimates for variables within a model may 
have different units from one another (because each has the same units as the 
variable it describes), the standardized  estimates are all on the same scale. 
Standardized  estimates from different variables within the same model can thus 
be directly compared to determine which has a greater effect on the dependent 
variable. 
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The p value is the probability of a type I error, a statistic used to assess the 
significance of a statistical test by evaluating the likelihood that the result could 
have occurred by chance. The alpha threshold chosen for this study was 0.05. 
The semi-partial R2 is a measure of how much each individual independent 
variable contributes to the R2 of the overall model. 
The overall model R2 can be interpreted as the proportion of the variability 
of the dependent variable that is accounted for by the predictors in the model. 
Summary statistics for the best model (the model which contains only 
significant predictors) are reported in the Results text. Some models in the 
summary tables include age and sex even if they did not reach significance. 
Because age and sex are variables of interest in many of the studies from which 
these datasets originate, they are included in the tables so their contribution to the 
overall model can be compared relative to other predictors. For example, the 
statistics in the table can be used to determine whether TTF or age accounts for 
more of the variance of a particular histochemical staining measure.  
Evaluation of Extreme Points 
No biological or methodological bases were found for the removal of 
subjects from the study. However, extreme points that met all of the following 
criteria were considered for exclusion from individual regressions:  1) The Cook’s 
distance value was greater than 4/N (the point is an “influential point”; Cook & 
Weisberg, 1982; Bollen & Jackman, 1990),  2) The Studentized residual was less 
than -2 or greater than 2 (the point is an “outlier”; Cook & Weisberg, 1982), and  3) 
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removal of the point changed the outcome of the regression test. All points that 
qualified for exclusion are listed in Table 4, and the effect of their removal from the 
relevant graph is discussed on a case-by-case basis. 
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Dataset Number 
of 
Subjects 
# Males # Females TTF Range (Yrs) 
NeuN 26 11 15 0.04-  8.25  
PV 26 11 15 1.82-10.03 
Orexin-A 36 18 18 0.15-  6.81 
BrdU 16 16 0 0.32-  3.79 
dMBP 29 13 16 1.15-10.89 
proBDNF+ puncta 36 19 17 0.43-  7.65 
proBDNF  
OD in GM 
36 19 17 0.43-  7.65 
proBDNF  
OD in WM 
36 19 17 0.43-  7.65 
proBDNF+ 
somata 
36 19 17 0.43-  7.65 
DCX 16 16 0 0.32-  3.79 
HA 29 13 16 1.15-10.89 
 
Table 1: Cohorts for cryostorage study 
A summary of subjects used to create the eleven datasets analyzed in the 
evaluation of cryostorage methods (Aim 1). The number of subjects and range of 
freezing times (total time frozen, TTF) are shown for each cohort. Some staining 
measures were acquired as double labels, and thus share a cohort and/or TTF 
range. These include NeuN and PV (same cohort, separate experiments), BrdU 
and DCX (same cohort, separate experiments), dMBP and HA (double label; same 
cohort and TTF range), and all proBDNF stains (different analysis measures 
derived from one batch of immunostained tissue). Abbreviations are as follows: 
NeuN= Neuronal Nuclei, PV= Parvalbumin, BrdU= bromodeoxyuridine, dMBP= 
damaged myelin basic protein, proBDNF= pro brain derived neurotrophic factor, 
DCX= doublecortin, HA= hyaluronic acid. 
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Dataset Antigen Antibody 
Host 
Company 
Neuronal Nuclei 
(NeuN) 
Soluble nuclear protein in 
neurons 
Mouse Chemicon 
Parvalbumin (PV) Calcium binding protein found 
in GABAergic interneurons 
Mouse Swant 
Orexin-A Excitatory neuropeptide 
hormone 
Goat Santa 
Cruz 
Biotech 
Bromodeoxyuridine 
(BrdU) 
Synthetic analog of thymidine; 
nuclear localization 
Mouse Chemicon 
Damaged myelin 
basic protein 
(dMBP) 
Amino acids 69-86 of guinea 
pig myelin basic protein 
Rabbit Millipore 
Doublecortin (DCX) Microtubule associated protein Rabbit Cell 
Signaling 
Hyaluronic acid 
(HA) 
HA, the major 
glycosaminoglycan component 
of neural extracellular matrix 
N/A 
(Cow-
derived) 
Millipore 
pro-Brain Derived 
Neurotrophic Factor 
(pro-BDNF) 
Precursor of BDNF, a member 
of the neurotrophin family of 
growth receptors 
Rabbit Alomone 
Labs 
 
Table 2: Antigens studied in batch processed datasets 
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Subject Age (Yrs) Sex CII 
AM204 6.1 M -0.820 
AM205 6.2 M 0.079 
AM198 7.8 F -0.095 
AM227 7.8 M 0.361 
AM228 7.9 M 0.477 
AM229 8.3 M 1.419 
AM299 8.5 F 0.850 
AM255 9.5 F 0.123 
AM202 10.3 F 0.451 
AM199 10.6 F 1.239 
AM194 11.9 F 2.259 
AM278 15.3 F 2.681 
AM288 15.9 M 3.148 
AM257 17.6 F 1.556 
AM190 18.0 F 1.531 
AM274 18.3 M 2.284 
AM161 19.2 F 1.405 
AM159 19.8 F 1.738 
AM177 20.9 F 6.729 
AM162 22.3 F 2.315 
AM196 22.9 F 2.943 
AM282 23.0 M 4.203 
AM243 24.4 M 2.991 
AM189 24.5 M 2.902 
AM034 26.1 M  N/A 
AM283 26.3 M 2.847 
AM181 27.5 F 5.890 
AM180 29.6 F 3.513 
AM121 30.2 M 12.373 
Table 3: Subjects for Aims 2-4 
Identification numbers, age in years, sex, and cognitive impairment index (CII) of 
the monkeys used in Aims 1-3. N=29, 13 males and 16 females. AM034 does not 
have a CII score because he was administered a different version of the cognitive 
testing battery than the other subjects. ID numbers of subjects used for immuno 
electron microscopy are in bold italics. AM336, a 21-year-old female used only for 
immuno EM, is not listed.  
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Figure 3: Timeline of Cryoprotection and Cryostorage Procedures 
The steps used to obtain, cryoprotect, section, and store tissue are shown. The 
total time frozen (TTF) measure encompasses the time between flash freezing the 
cryoprotected tissue block (Step #5) to when 30 micron sections are thawed on 
the first day of histochemical processing (Step #10). 
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Figure 4: Anatomical Bounds and Regions of Interest  
Coronal sections 30 microns thick were selected from between the levels shown. 
A: Rostral bound. B: Caudal bound, defined as before the temporal pole (TP) 
connected to the rest of the section. Eight sections per monkey were used. The 
outlines show the specific regions of interest analyzed for the corpus callosum 
(CC) and the cingulum bundle (CB).  
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Figure 5: Example double label immunohistochemistry for CC1 / PDGFRa markers 
Oligodendroglia precursor cells are shown in diaminobenzidine (brown) and 
oligos in Vector SG (blue) in all panels. Example staining is shown in A: corpus 
callosum of the young male monkey AM229, B: corpus callosum of the aged 
male monkey AM189, C: cingulum bundle of AM229, and D: cingulum bundle of 
AM189. 
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Figure 6: Image analysis using percent area stained and fluorescence intensity measures 
A: An example of dMBP staining in the corpus callosum, with only brightness and 
contrast adjusted. B: The image shown in A after thresholding, the last step of the 
procedure for obtaining percent area. C: An example image pixel histogram, with 
the six partitions used to calculate fluorescence intensity labeled and numbered. 
D: An example of a dMBP image with low percent area and intensity measures. E: 
Representative high HA staining. F: Representative low HA staining. Scale bar = 
100 microns.  
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Figure 7: Correlations between percent area and fluorescence intensity measures  
Percent area versus fluorescence intensity of A: damaged myelin basic protein 
(dMBP) in the cingulum bundle (CB); B: dMBP in the corpus callosum (CC); C: 
hyaluronic acid (HA) in the CB; D: dMBP in the CC.  
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CHAPTER THREE: EVALUATION OF LONG-TERM CRYOSTORAGE OF 
BRAIN TISSUE SECTIONS ON QUANTITATIVE HISTOCHEMISTRY 
Approach 
To determine whether tissue sections that were processed with the Rosene 
cryoprotection protocol (Rosene et al., 1986) and stored at -80°C for a period of 2 
weeks to 10.9 years are still adequate for IHC, the present study analyzed whether 
total time in frozen storage (total time frozen or TTF) affects measures of 
quantitative histochemistry. TTF encompasses the period of time starting when a 
cryoprotected tissue block is frozen using -75°C isopentane, and ending the day 
vials containing tissue sections from that block were thawed for IHC (Figure 3). 
There is one freeze-thaw cycle within this TTF period, occurring when the block is 
sectioned, but sections remain thawed for less than 24 hours before being frozen 
in 15% glycerol. The histochemical measure in each of 11 datasets (e.g. NeuN cell 
counts, or percent area of fluorescent HA staining) was the dependent variable in 
all analyses. Since the staining measures were produced from several different 
studies, and each study used a different subject cohort and was performed on a 
different date, each staining measure had different data for its associated “age” 
and “TTF” variables. The original studies are cited in the corresponding Results 
paragraphs, below. Examples of immunohistochemical staining from three of the 
eleven studies are shown in Figure 8. 
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Results of long-term cryostorage on quantitative histochemistry 
Results summary 
Out of eleven histochemical measures tested (NeuN, PV, Orexin-A, BrdU, 
pro-BDNF somata, pro-BDNF puncta, pro-BDNF optical density in white matter, 
pro-BDNF optical density in grey matter, DCX, hyaluronic acid, and damaged 
myelin basic protein), the length of time in cryostorage at -80°C had no effect on 
five of the outcome measures. Labels that did not show any significant effect of 
TTF on immunohistochemistry were NeuN, Orexin-A, BrdU, and pro-BDNF puncta. 
Five of the remaining measures, pro-BDNF optical density in the white matter, pro-
BDNF cell counts, DCX, dMBP fluorescence intensity, hyaluronic acid percent 
area) correlated significantly to total time frozen (TTF). The last measure, PV cell 
counts, approached a significant correlation with TTF. Several possible 
interpretations of these findings will be explored in the Discussion. Statistics for 
each of the eleven measures are described below, listed in Table 4, and shown in 
Figure 9. 
Histochemical labeling unaffected by cryostorage time 
NeuN cell counts 
NeuN is a commonly used marker for neurons in which it mainly labels 
nuclei. It is now known that NeuN is the Fox-3 splicing factor (Kim et al., 2009). 
Stereological counts of NeuN+ neurons in primary visual cortex of the aging 
monkey brain showed no effect of age (p=0.929, R2<0.001) as previously reported 
(Giannaris & Rosene, 2012). When analyzed for effects of cryostorage, the 
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correlation between TTF and NeuN was not significant (p=0.795, R2=0.003, Figure 
9A). The relationship between TTF and NeuN was still not significant when 
controlling for effects of age and sex in a multiple regression analysis (TTF 
p=0.723, semi-partial R2=0.006; Table 4).  
Orexin-A Cell Counts 
Orexin-A, also known as hypocretin 1, is an excitatory neuropeptide 
hormone (de Lecea et al., 1998). Stereological counts of Orexin-A positive neurons 
in the hypothalamus of the aging monkey brain showed a significant negative 
relationship of age with cell numbers in males but not females (Roberts & Rosene, 
unpublished; p=0.026, R2=0.138). While testing regression assumptions, the 
interaction between TTF and age for this cohort was found to be significant 
(p=0.032). Because of a positive correlation between TTF and age (r=0.317), the 
significant interaction variable indicates that, for the cohort in the orexin study, 
tissue from aged monkeys was stored in the freezer longer than tissue from young 
monkeys. Despite this confound, the correlation between TTF and orexin cell count 
was not significant in any of three models considered: 1) A single linear regression 
(p=0.834, R2=0.001; Figure 9B), 2) a multiple regression model that included the 
TTF-age interaction variable, TTF, age, and sex (TTF p=0.087, semi-partial 
R2=0.072; Table 4), or 3) a multiple regression model which contained only the 
TTF-age interaction variable, TTF, and age (same as #2 but excluded sex due to 
its non-significant p value). In this third model, TTF p=0.103 and semi-partial 
R2=0.064.  
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BrdU Cell Counts 
BrdU is a thymidine analogue that incorporates into the DNA of dividing 
cells, and is used as a marker of newly generated cells. Counts of BrdU+ neurons 
in the dentate gyrus of the hippocampus of the aging monkey brain showed a 
significant reduction with age (Ngwenya et al., 2015; p=0.008, R2=0.407). When 
analyzed for effects of time in cryostorage, there was no significant correlation 
between TTF and BrdU+ neurons (p=0.293, R2=0.078; Figure 9C). The 
relationship between TTF and BrdU+ neurons was still not significant when 
controlling for age (TTF p=0.732, semi-partial R2=0.006; Table 4). This study was 
conducted using only male subjects, so sex was not included as a predictor in the 
regression analysis.  
Pro-BDNF Measures 
Pro-BDNF is the precursor form of Brain Derived Neurotrophic Factor, the 
most prevalent member of the neurotrophin family of growth factors (Mufson et al., 
1999; Poo, 2001; Lu et al., 2005; Barker, 2009). Pro-BDNF staining was analyzed 
in three ways in Inferior Parietal Lobule (IPL) of the aging monkey brain (Robinson 
& Rosene, 2012): Positively stained cell bodies, extracellular puncta, and overall 
densitometry or Optical Density (OD) of gray matter and of white matter. Two of 
these measurements, pro-BDNF cell numbers in gray matter and OD in white 
matter, showed a significant TTF related increase and are thus covered in the next 
section. However, pro-BDNF puncta and pro-BDNF OD in gray matter did not 
correlate significantly with age or with any measures of freezing time. Specific 
results for these two measures are as follows: 
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 Pro-BDNF puncta: Calibrated photomontages of the monkey inferior 
parietal lobule (IPL) were acquired under matched conditions and puncta 
automatically identified with Image J. Counts of puncta demonstrated no significant 
effect of age (Robinson & Rosene, unpublished; p=0.885, R2=0.001). When 
analyzed for effects of time in cryostorage, the correlations between TTF and 
puncta was not significant (p=0.926, R2<0.001; Figure 9D). This relationship was 
also not significant in a multiple regression model which included TTF, age, and 
sex (TTF p=0.843, semi-partial R2=0.001). 
 Pro-BDNF Gray Matter Optical Density:  Because detection of puncta 
required thresholding, we also analyzed total pro-BDNF optical density in the IPL 
with Image J using the same image montages. Results from the original study 
indicated that there was a significant age-related decrease in total pro-BDNF OD 
in the gray matter (Robinson & Rosene, unpublished; p=0.045, R2=0.112) but not 
in the white matter. When analyzed for effects of time in cryostorage, there were 
no significant correlations between TTF and gray matter OD (p=0.959, R2<0.001; 
Figure 9E). This relationship was still not significant in a multiple regression model 
that included TTF, sex, and age (TTF p=0.848, semi-partial R2=0.001). 
The remaining two pro-BDNF measures, OD in the white matter and pro-
BDNF+ cell bodies, did correlate significantly with TTF. These data are reported in 
the following section. 
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Histochemical Labeling Showing Relationships with Cryostorage Time 
Pro-BDNF White Matter Optical Density: In the original study, no change 
was found in pro-BDNF white matter OD with age (p=0.103, R2=0.076). When 
analyzed for effects of time in cryostorage, there was a significant increase in pro-
BDNF white matter OD with increasing TTF (p=0.048, R2=0.110; Figure 9F). This 
relationship was still significant in a multiple regression model that included TTF, 
age, and sex (TTF p=0.031, semi-partial R2=0.126; Table 4).  
Pro-BDNF Cell Counts: The number of pro-BDNF positive cell bodies 
detected with Image J showed an unexpected effect of age with cell counts 
increasing (p=0.011, R2=0.177; Robinson & Rosene, unpublished). When 
analyzed for effects of time in cryostorage, pro-BDNF cell counts increased 
significantly with increased TTF (p=0.025, R2=0.139; Figure 9G). The relationship 
between TTF and pro-BDNF cell counts was still significant in a multiple linear 
regression model that included TTF, age, and sex (TTF p=0.008, semi-partial 
R2=0.165; Table 4). 
 Summary of Pro-BDNF: To summarize, of the four pro-BDNF measures in 
the inferior parietal lobule, both pro-BDNF cell counts and OD in the white matter 
increase significantly with TTF. Pro-BDNF puncta and OD in the gray matter do 
not change with TTF. 
Doublecortin Cell Counts 
DCX is a microtubule-associated protein found intracellularly in the somata 
and processes of immature neurons and neuronal precursor cells (Brown et al., 
2003). Counts of DCX in hippocampus of the aging monkey brain showed a 
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significant decrease with age (Ngwenya et al., 2015; p=0.002, R2=0.507). When 
analyzed for effects of cryostorage, there was a significant decrease in DCX cell 
counts with increasing TTF (p=0.033, R2=0.285; Figure 9H). The relationship 
between TTF and DCX only approached significance in a multiple regression 
model that included TTF and age (TTF p=0.086, semi-partial R2=0.104; age 
p=0.006, semi-partial R2=0.325; Table 4). Although the age-TTF interaction 
variable was not significant (p=0.193), the subtle correlation between TTF and age 
(r=0.322, p=0.224) may be confounding the relationship between TTF and DCX. 
Damaged Myelin Basic Protein Fluorescence Intensity: 
As described in the Introduction, myelin basic protein (MBP) is a component 
of the myelin sheath (e.g. Harauz et al., 2007). The damaged myelin basic protein 
antibody (dMBP) targets an epitope on MBP that is concealed when MBP is intact, 
and is exposed when MBP is damaged or denatured (Matsuo et al., 1997). The 
dMBP antibody is thus used as a marker of myelin damage (e.g. Ihara et al., 2010; 
Matsuo et al., 1997, 1998; Wu et al., 2012; Yamamoto et al., 2009). The dMBP 
fluorescence intensity was unchanged with age in the cingulum bundle when the 
entire cohort of 29 monkeys was considered (p=0.077, R2=0.111; Chapter 5). 
When analyzed for effects of time in cryostorage, a quadratic model fit the data 
better than a linear model. While the linear model does not show a significant 
relationship between TTF and dMBP (p=0.102, R2=0.096), this relationship is 
significant in all three quadratic models considered: 1) a multiple regression model 
that includes TTF2, TTF, age, and sex (overall model p=0.012, R2=405; Table 4), 
2) a multiple regression model that includes only significant predictors (same as 
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#1 but without age, excluded due to its non-significant p value; overall model 
p=0.014, R2=0.340), and 3) a multiple regression model containing only TTF2 and 
TTF (overall model p=0.040, R2=0.220; Figure 9I). 
Hyaluronic Acid Percent Area 
As described in the Introduction, hyaluronic acid (HA) is an extracellular 
glycosaminoglycan that forms a branching scaffold structure to which other neural 
extracellular matrix (ECM) components attach (Scott et al., 1991; reviewed by 
Sherman & Back 2008 and Bignami et al., 1993). The percent area of HA in the 
cingulum bundle significantly increases with age (p=0.025, R2=0.172; Chapter 5). 
When analyzed for effects of cryostorage, quadratic models were a stronger fit for 
the data than linear models. However, the relationship between TTF and HA was 
significant in all models considered: 1) a linear regression model, which showed a 
significant increase in HA with increasing TTF (p=0.038, R2=0.149), 2) a quadratic 
multiple regression model that included TTF2, TTF, age, and sex (overall model 
p=0.001, R2=0.548; Table 4), 3) a quadratic multiple regression model that 
included only significant predictors (same as #2 but without sex, which was 
excluded due to its non-significant p value; overall model p= 0.001, R2=0.500), and 
4) a quadratic multiple regression model that included only TTF2 and TTF 
(p=0.002, R2=0.392; Figure 9J). 
Parvalbumin Cell Counts 
PV is a calcium-binding protein that is used as a marker of sub-populations 
of GABAergic interneurons (Andressen et al., 1993). Stereological counts of PV+ 
neurons in primary visual cortex of the aging monkey brain showed no effect of 
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age (p=0.404, R2=0.029; Giannaris & Rosene, unpublished). When analyzed for 
effects of cryostorage, the relationship between TTF and PV was more accurately 
fit by a quadratic model than a linear model. The model that contained only TTF2 
and TTF as independent variables was best, and shows a quadratic relationship 
that approaches significance (overall model p=0.075, R2=0.202; Figure 9K). The 
relationship between TTF and PV is also significant in a multiple regression model 
that contains TTF2, TTF, age, and sex (overall p=0.280, R2=0.206, TTF p=0.045; 
Table 4). For comparison, a linear regression between TTF and PV has p=0.601 
and R2=0.012. 
Discussion 
Summary of Results 
While published studies (e.g. deOlmos et al., 1978; Hoffman and Le, 2004) 
recommend approaches for long term frozen cryostorage of sections for IHC, to 
our knowledge there has been no systematic, quantitative assessment of how this 
storage affects subsequent immunohistochemical processing. In this study, we 
assessed whether various quantitative measures of histochemical staining are 
affected by length of time in -80°C cryostorage. Results from analysis of eleven 
different histochemical procedures and the resulting data measures indicate that 
storage for up to 10 years (most of that time in 15% buffered glycerol) at -80°C has 
a subtle but statistically significant effect on a subset of staining measures, as 
assessed with quantitative histochemistry. The data sets tested include analyses 
of chromogen IHC for NeuN, Parvalbumin, Orexin-A, BrdU, Pro-BDNF, and DCX, 
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fluorescent IHC for dMBP, and a fluorescent histochemical stain for HA. 
Measurement techniques of these studies included stereological counts, image 
segmentation and optical density, fluorescent percent area stained, and 
fluorescence intensity. Notably, six datasets, those measuring DCX+ neurons, 
PV+ neurons, HA percent area, dMBP fluorescence intensity, pro-BDNF+ cells, 
and pro-BDNF optical density in the white matter, did show significant associations 
with cryostorage time. 
Discussion of commonly used cryoprotection and cryostorage methods 
Much of the data concerning the effects of freezing conditions on cells and 
tissue comes from studies on cryogenic freezing and tissue banking methods 
which are techniques for freezing living cells and tissues in ways that preserve 
their viability (e.g. Morris et al., 2006; Umemura et al., 2011). To summarize, 
freezing causes damage to tissues in two main ways: formation of ice crystals 
during the freeze-thaw process, and slow-rate reactions while the tissue is frozen 
(i.e. dehydration). Cryoprotectants are designed to prevent the former and to 
minimize the latter, with the expectation that the effects of any slow reactions will 
be negligible over the storage timeframe.  
 While information from cryogenic freezing studies is relevant to the practice 
of freezing fixed tissue for IHC, tissue for IHC differs from tissue banking samples 
in how it is prepared. Other than differences in fixation (tissue for IHC is fixed and 
tissue for cryogenic freezing is not), the key difference in processing is the number 
of freeze-thaw cycles the tissue goes through. Tissue for IHC goes through several 
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freeze thaw cycles as it is processed (Figure 3), but tissue banking samples are 
frozen only once. Freeze-thaw cycles can damage tissue through the formation of 
ice crystals, which damage morphology by rupturing cell membranes and damage 
cytoarchitecture by creating “holes” that move tissue structures out of their natural 
spatial configurations. If ice crystals cause cells to burst and lose their contents, 
this form of freezing damage could cause loss of specific proteins or peptides from 
the tissue, thus affecting quantitative IHC. However, damage from ice crystals is 
readily apparent (Figure 10), so the likelihood of ice crystals introducing a subtle 
confounding effect in IHC studies is low—if the cryoprotectant or freezing 
conditions fail to prevent formation of ice crystals, the freezing artifact will be visible 
in the tissue.  
 After initial freezing, several processes can damage tissue during long-term 
storage. Two examples are dehydration, and changes in pH (induced by 
crystallization of buffer salts) which may in turn affect protein structure through 
changes in phosphorylation state and ionic interactions between charged amino 
acids. Whether or not these slow-rate reactions are relevant in any given 
circumstance depends on the cryoprotectant that is used and the antigen being 
studied.  
 An overview of common cryoprotectants for IHC is below, followed by a 
theoretical discussion of how the structural properties of specific antigens may 
render them vulnerable to slow-rate reactions while frozen. 
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Commonly Used Cryoprotectant Solutions 
For the purposes of quantitative IHC, all published cryoprotectants to our 
knowledge are either sucrose-based or glycerol-based, but there has not been a 
systematic comparison of IHC quality between the two means of storage. 
Endorsed by several early papers for cryoprotection of fixed tissue (see for 
example the discussion in Rosene et al., 1986), 30% sucrose remains a common 
cryoprotectant. However, its effectiveness at preventing freezing artifact is limited 
in tissue blocks larger than 60cc, where it produces inadequate and “occasionally 
disastrous” results (Rosene et al., 1986). Sucrose-based cryoprotectants also 
cause tissue shrinkage, which limits the usefulness of the tissue for anatomical 
studies (Rosene et al., 1986). For example, in one study the average shrinkage of 
four monkey brain blocks cryoprotected with sucrose was 6.5%, while the average 
shrinkage of four monkey brain blocks cryoprotected with glycerol-DMSO was 
0.04% (Rosene et al., 1986). 
 Besides the main components of buffer and either sucrose or glycerol, 
several additives are sometimes used. Dimethyl sulfoxide (DMSO), an 
organosulfur compound, is recommended as an additive to the 15% glycerol 
cryoprotectant in which large tissue blocks are immersed (Rosene et al., 1986) 
because it improves the rate of glycerol penetration into blocks before initial 
freezing. The 30% sucrose cryoprotectant recommended for IHC by deOlmos and 
colleagues (de Olmos et al., 1978) and Watson and colleagues (Watson et al., 
1986) contains the additives ethylene glycol (30%) polyvinylpyrrolidone (PVP-40; 
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1%). Ethylene glycol is a common component of commercial antifreeze. PVP-40 
is a polymer which is thought to affect the loss of water through cell membranes 
during the freezing of unfixed cells (such as for tissue banking, e.g. Umemura et 
al., 2011). A study that applied cryostorage methods for in situ hybridization 
histochemistry samples (Lu & Haber, 1992) used the deOlmos cryoprotectant but 
omitted the PVP-40.   
Possible Effects of 15% Glycerol on DCX, pro-BDNF, and HA 
There are three plausible explanations for the significant relationships 
between freezing time and some staining measures: 1) Water ice altered the tissue 
or the antigen over time, 2) the non-water components of the cryoprotectant altered 
the tissue or the antigen over time, or 3) the significant results reflect the unlikely 
possibility of six type I errors (i.e., the results were significant by chance alone, and 
there is no “real” effect of freezing time). This is extremely improbable, but 
possible. 
 Explanation 1 is unlikely because if ice crystals were affecting the tissue, 
the effects of freezing should have been significant for all antigens tested. The 
cohorts of subjects that showed significant effects of freezing (e.g. pro-BDNF) and 
those which didn’t (e.g. NeuN) had a similar range of TTF values, and the 
cryoprotection procedure for all subjects of all cohorts was the same. There is no 
obvious reason to believe that water itself would affect some antigens differently 
than others.  
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 Explanation 2 is based on the separation of glycerol-based cryoprotectants 
into a water fraction and a glycerol fraction during freezing, as described by tissue 
banking methods (e.g. Morris et al., 2006; Umemura et al., 2011). While most of 
the separation likely happens in the early stage of freezing as small ice crystals 
fuse into larger ones (termed “recrystallization,” occurring fastest at temperatures 
above -30°C; Asahina et al., 1970), ice crystal formation may be able to continue 
more slowly at lower temperatures. Our cryoprotection methods (Rosene et al., 
1986) adequately prevent ice crystal formation within the tissue, as evaluated by 
histological assessment. However, the continual formation of ice crystals not within 
the tissue but within the storage vial (either formation of new ice crystals or 
“recrystallization”—smaller ice crystals fusing into larger ones) can increasingly 
separate the glycerol-salt portion of the cryoprotectant from the growing water ice 
portion. Since cells and tissue remain in the glycerol-based fragment (which is how 
the glycerol protects tissue banking cells from ice crystals), they are exposed to 
increasingly hypertonic environments. Additionally, because buffer salts can 
crystallize at low temperatures and increased concentrations (Pikal-Cleland et al., 
2000; Murase et al., 1989), the pH of the tissue environment may change, affecting 
phosphorylation state and protein conformation. Therefore, the extent to which a 
protein’s structure relies on the protonation or phosphorylation state of amino acids 
may render it vulnerable to such storage environments. It is plausible that long-
term freezing conditions could alter the structure of antigens, affecting antibody 
recognition and thus quantitative IHC. 
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 To determine whether susceptibility to such conditions could explain the 
significant relationships with freezing time observed in the present study, we 
conducted a structural analysis of nine of the eleven antigens (all except dMBP 
and HA). Data concerning protein composition and modifications was obtained 
from Uniprot (2014). 
 The structural features considered included percentage and total number of 
each individual amino acid within the protein, with a focus on the number and 
percentage of specific amino acids that can confer specific structural properties to 
proteins, specifically the number and proportion of charged amino acids (which 
would be most affected by pH changes), number and proportion of prolines (which 
have a pyrrolidene ring side chain that constrains protein structure, stabilizing or 
destabilizing the conformation of many proteins depending on the conditions; 
Prajapati et al., 2007), and number and proportion of serines (a common site of 
phosphorylation, a post-translational modification that affects the function of 
proteins often by inducing a conformational change; Kim et al., 2011). This 
structural analysis did not reveal any commonalities amongst the antigens that 
appear to be affected by frozen storage. 
 It is possible that the various dehydration-based effects of glycerol 
cryoprotectants that are observed in tissue banking protocols (i.e. conformation 
changes due to low pH) do not apply to the fixed tissue used for IHC. It is thought 
to be the case that stronger fixation impedes the movement of water through the 
tissue, as shown by slower replacement of water by cryoprotectants in tissue 
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treated with stronger fixatives (Rosene et al., 1986), so fixation may mitigate the 
effects of potentially dehydrating conditions. 
 Explanation #3 for the observed significant effects of freezing time is that 
they are an artifact of the statistical methods used. With the number of correlations 
run in this study, it could be argued that there is a high risk of type I error (false 
positives) from multiple comparisons. However, this is not the case because each 
staining measure was compared only with the measures of freezing time and ages 
that corresponded to its cohort. If all staining measures were from the same cohort 
of subjects such that the TTF data were the same for all correlations (and thus 
repeatedly compared against each staining measure), then the multiple 
comparisons would not be appropriate. Furthermore, with an alpha of 0.05, 
approximately one in twenty tests would be expected to result in false positives. 
However, six of eleven antigens showed significant relationships with TTF, so it is 
extremely improbable that all of these effects are type I errors. 
 A more relevant statistical consideration is whether the effects of freezing, 
even if valid, are a strong enough effect to be worthy of routine consideration in 
histochemical studies. Analysis of the R2 values of each statistically significant 
relationship (representative of the proportion of variance accounted for by the 
relationship) puts the practical impact of these relationships into context. For 
example, the correlation between HA percent area and TTF has an R2 of 0.149, 
indicating that changes in TTF explain about 15% of the variance in the HA data. 
Arguably, 15% is not a high enough proportion of variance to make TTF a variable 
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of interest. However, if we were to err on the side of caution and use multiple 
regression to control for the effects of TTF while correlating HA percent area to 
other measures from the original study, we see that the p value for TTF as an 
individual independent variable (as opposed to the overall p value of the model; 
see the explanation of variables in Methods) rises so that it is no longer significant. 
In other words, although HA and TTF correlate significantly to one another, the 
strength of the association between them is not on the same scale as the 
relationship between HA and other independent variables in the original study. For 
instance, the correlation between HA and dMBP has an R2 =0.636 and p<0.0001 
(Chapter 5).  
 Considering that many of the significant correlations between staining 
measures and TTF reported in the present study have R2 values at the same 10-
15% level (Table 4), indicating that the time in cryostorage only accounts for 10-
15% of the variance in the histochemical staining measure, analyzing the time in 
frozen storage as a routine practice may not be worth the time and resources. 
Even if the observed effects of frozen storage time are “real,” it is possible that they 
may be safely ignored depending on the quality of the cryoprotection protocol used 
and the specifics of the primary study. 
Comparison within pro-BDNF cases 
The pattern of significance for pro-BDNF was unexpected because the 
number of stained cell bodies in gray matter increased with greater TTF, but the 
number of gray matter puncta and the overall gray matter optical density were 
  
66
unaffected. Furthermore the overall white matter optical density also increased 
with TTF.  
 Since the pro-BDNF antigen was analyzed in three ways (cell counts, 
puncta counts, and optical density) and in three compartments/areas (optical 
density in the gray matter, optical density in the white matter, puncta in the gray 
matter, and somata in the gray matter), and some of these measures were affected 
by cryostorage time and others were not, comparison between these cases may 
provide information as to potential causes of the effects of cryostorage. For 
example it may be the case that the subcellular compartment or location in the 
tissue is as important in conferring cryostorage vulnerability as the protein 
composition of the antigen. In other words, if an antigen is vulnerable to being 
deformed over time by some aspect of the freezing environment, the location of 
the antigen may affect the extent to which it is exposed to or protected from 
degradation. Alternatively, time in frozen storage may act as antigen retrieval for 
some antigens (those concealed within certain cellular compartments or 
subcellular structures) but not others. This may be one explanation for the 
unexpected finding that some histochemical measures increased with longer time 
in frozen storage. 
Recommended Methods for Cryostorage 
As previously described (Rosene et al., 1986), our recommended methods 
for cryostorage of rhesus monkey brain tissue are summarized as follows: The 
brain is first perfused with Krebs buffer at 4°C, then fixed by perfusion with 4% 
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paraformaldehyde in 0.1 M phosphate buffer. After removal from the skull, the 
brain is stored in 10% glycerol and 2% DMSO in buffer at 4°C for 1-3 days, then 
transferred to 20% glycerol and 2% DMSO at 4°C for at least 4 days. The brain is 
cut into anatomically-defined blocks before freezing (such as an occipital lobe 
block) so researchers can use the block relevant to their studies without thawing 
unneeded regions of the brain. The initial freezing setup consists of 500 mL of 
isopentane in a Teflon beaker, chilled to -75°C by a surrounding bath of absolute 
alcohol and dry ice. Prior to freezing the block, it is rinsed in room temperature 
isopentane to remove the glycerol solution from the surface. The block is then 
submerged into the chilled isopentane, and maintained there for 1 hour with 
occasional stirring to enable the tissue to reach -75°C. Once at this temperature, 
the block is wrapped tightly in foil and stored at -80°C until cut. 
 To cut sections on a microtome with a freezing stage, the block must be 
affixed to the stage with water and surrounded by pulverized dry ice. Sections are 
then cut and placed in vials with 15% glycerol in buffer. Vials are placed at 4°C 
overnight to allow the sections to equilibrate with the solution, and then placed into 
a -80°C freezer for storage until needed for IHC. 
 During immunohistochemical processing of tissue sections, it is important 
to process all sections in the same batch of reagents, for the same amounts of 
time—a technique referred to as “batch processing.” This is crucial to minimize 
variations in staining quality between subjects or sections due to slight differences 
in reagent strength or incubation timing. 
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Conclusions 
The present study demonstrates that the recommended methods described 
above should preserve tissue quality for quantitative IHC up to a period of ten 
years. There is no reason to believe that these methods would work differently for 
rodent brain tissue, so cryostorage of mouse or rat brains using the recommended 
methods should result in tissue samples of adequate quality for quantitative 
histochemistry. However, these findings may not be applicable to human brain 
samples, since the use of perfusion-fixation techniques is impossible. 
When employing freezing and cryoprotection methods other than those 
recommended here, it is advisable to evaluate IHC quality as follows: Perform IHC 
on tissue samples that have been in frozen storage the longest, alongside tissue 
that has recently been processed and frozen. Use good batch processing 
techniques as described to ensure that slight differences in timing or solution 
concentration do not affect staining. Quantify the label, and perform multiple 
regression analysis to determine whether time frozen affects staining when 
controlling for other significant factors of interest. If a significant association exists 
between time frozen and the quantified staining measure, multiple regression 
analysis can be used to control for the confounding effects of freezing time in the 
data. Alternatively, only tissue stored for short periods of time can be used for the 
sensitive antigen, and older tissue could be reserved for studies with other 
antigens. 
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Staining 
Measure 
(Dep. 
Variable) 
Indep. 
Variable 
 Estimate 
(95% CI) 
Standardized 
 Estimate 
p value Semi-
Partial 
R2 
NeuN TTF -4262.405 -0.078 0.723 0.006 
Age -11769 -0.002 0.994 <0.001 
Sex 12222803 0.131 0.549 0.017 
   
Model R2= 0.020 
PV 
 
TTF2 2.597 
(-0.050, 5.244) 
1.805 0.054 0.157 
TTF -10578 
(-20871, -284.110) 
-1.876 0.045 0.173 
Age 55376 0.074 0.723 0.005 
Sex -19760 -0.002 0.992 <0.001 
   
Model R2= 0.206 
Orexin-A TTF*Age 0.442 
(0.041, 0.843) 
1.357 0.032 0.116 
TTF -7.188 
(-15.488, 1.111) 
-0.885 0.087 0.072 
Age -537.209 
(-857.666, -216.752) 
-0.924 0.002 0.269 
Sex -970.000 -0.117 0.452 0.133 
   
Model R2= 0.288 
BrdU TTF -0.061 -0.079 0.732 0.006 
Age -25.552 
(-45.864, -5.239) 
-0.612 0.018 0.334 
Sex N/A N/A N/A N/A 
   
Model R2= 0.412 
dMBP 
Intensity 
TTF2 2.36x10-6 
(1.71x10-7, 4.55x10-6) 
2.388 0.036 0.123 
TTF -9.20x10-3 
(-1.96x10-2, 1.24x10-3) 
-1.935 0.081 0.082 
Age 0.180 0.260 0.120 0.064 
Sex 3.757 
(0.0735, 7.440) 
0.356 0.046 0.110 
   
Model R2= 0.405 
pro-
BDNF 
puncta 
TTF 0.00003776 0.034 0.843 0.001 
Age 0.00176 0.012 0.944 <0.001 
Sex 0.52765 
(-0.10115, 1.15645) 
0.292 0.097 0.084 
   
Model R2= 0.084 
pro-
BDNF 
GM OD 
TTF -0.00000248 -0.032 0.848 0.001 
Age -0.00360 
(-0.00702,  
-0.00018570) 
-0.357 0.039 0.124 
Sex -0.02034 -0.161 0.339 0.025 
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Model R2= 0.138 
pro-
BDNF 
WM OD 
TTF 0.00001655 
(0.00000159, 
0.00003151) 
0.357 0.031 0.126 
Age 0.00183 
(-0.00012273, 
0.00379) 
0.304 0.065 0.091 
Sex -0.00212 -0.028 0.861 0.001 
   
Model R2= 0.205 
pro-
BDNF 
Somata 
TTF 6.27x10-6 
(0.00000179, 
0.00001075)  
0.408 0.008 0.165 
Age 8.96x10-4 
(0.00031058, 
0.00148) 
0.449 0.004 0.197 
Sex -0.00181 -0.072 0.618 0.005 
   
Model R2= 0.352 
DCX TTF -3.610  
(-7.802, 0.582) 
-0.340 0.086 0.104 
Age -346.482 
(-573.541, -119.423) 
-0.603 0.006 0.325 
Sex N/A N/A N/A N/A 
   
Model R2= 0.611 
HA % 
Area 
TTF2 2.58x10-6 
(9.55x10-7, 4.20x10-6) 
3.067 0.003 0.203 
TTF -0.01038 
(-0.01812, -0.00264) 
-2.564 0.011 0.144 
Age 0.19057 
(0.01931, 0.36183)  
0.323 0.031 0.099 
Sex 2.11653 0.236 0.113 0.048 
    
Model R2= 0.548 
Table 4: Summary of Regression Statistics between Total Time Frozen and Histochemical Staining 
Measures 
Abbreviations are as follows: NeuN = Neuronal Nuclei, PV=Parvalbumin, 
BrdU=bromodeoxyuridine, dMBP=damaged myelin basic protein, proBDNF= pro 
brain derived neurotrophic factor, DCX=doublecortin, HA=hyaluronic acid. The 
95% confidence interval (CI) is shown only for the  estimates of predictors that 
approach or attain significance. “Model R2” is the un-adjusted R2 for the model that 
includes the variables shown.  
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Figure 8: Examples of Immunohistochemical Staining in Tissue with Short versus Long Cryostorage 
Times 
Staining shown in age- and region-matched tissue with short (left column) and long 
(right column) cryostorage times. Immunohistochemical labels are A-B: NeuN, C-
D: Orexin-A, and E-F: Doublecortin. Scale bar= 50 microns. 
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Figure 9: Correlations between total time frozen and histochemical staining 
Total time frozen (TTF) in years versus staining measures for the following 
antigens: A: NeuN, a marker of neurons; B: Orexin-A, an excitatory neuropeptide 
hormone produced by a subpopulation of neurons; C: Bromodeoxyuridine (BrdU), 
a marker of newly generated cells; D: puncta positive for pro brain derived 
neurotrophic factor (proBDNF), the precursor form of the BDNF growth factor 
(proBDNF+ puncta); E: proBDNF optical density (OD) in the gray matter; F: 
proBDNF OD in the white matter; G: proBDNF+ neuronal somata; H: doublecortin 
(DCX) a marker of immature neurons and neuronal precursors; I: damaged myelin 
basic protein (dMBP) fluorescence intensity; J: hyaluronic acid (HA) percent area; 
K: Parvalbumin, a calcium-binding protein used to label a subpopulation of 
GABAergic interneurons. Antigens in A-E do not correlate significantly with TTF. 
Antigens in F-J do have a significant relationship with TTF, and the relationship 
between TTF and the antigen in K (DCX) approaches significance.  
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Figure 10: Example of Freezing Artifact  
The ventral bank of cortical area 46 (layer 1 at top) from a brain that was not 
effectively cryoprotected. Freezing artifact is apparent as numerous vacuoles that 
disturb the normal laminar cytoarchitecture of the cortex. A: Nissl stain. B: 
Immunohistochemical staining for microtubule associated protein 2 (MAP2). Scale 
bar = 50 microns. 
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CHAPTER FOUR: ASSESSMENT OF dMBP ANTIBODY SPECIFICITY 
Materials and methods 
Preabsorption control protocol 
Aliquots of the peptide against which the dMBP antibody was raised (guinea 
pig MBP residues 69-86) were obtained from GenScript and stored at -20°C. To 
prepare for use, one aliquot of the peptide, in the form of lyophilized powder, was 
dissolved in distilled water to a concentration of 1mg/mL. 
The concentration of the dMBP antibody stock was reported by the 
manufacturer as approximately 1mg/mL. Therefore the concentration of the 1:750 
working solution used for the present studies is a concentration of approximately 
1.33 µg/mL, and 2 mL of working solution contains 2.67 µg.  
To perform the preabsorption control experiment, four conditions of primary 
antibody solution were prepared. The first contained the dMBP 1:750 in potassium 
phosphate buffered saline (KPBS) pH 7.3 with 0.5% triton X-100 and no peptide. 
This condition was intended as a positive control, so other conditions could be 
compared to the standard level of staining. The second condition was the same as 
the first, except with the addition of 40x peptide (40 times the amount of antibody 
by mass, or 107 uL of peptide solution per 2mL total volume of antibody solution). 
The third condition was the same as the first, except with the addition of 80x 
peptide. The last condition was a minus primary antibody condition as a batch 
control. Once mixed, these solutions were placed on a rocker at 4°C overnight to 
enable the antibody to bind to the peptide. 
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The next day, the solutions were removed from storage and spun for 30 
seconds in a microcentrifuge at room temperature. The supernatant of each vial 
was pipetted into new containers and stored at 4°C until used in the primary 
antibody incubation step of the dMBP immunofluorescence protocol described in 
Chapter 2. 
Immunohistochemistry for electron microscopy (EM) 
Immunofluorescent control for EM: A few tissue sections (1-3 per monkey) 
were processed using a slightly modified version of the dMBP 
immunofluorescence protocol described in Chapter 2. These sections were 
intended: 1) as a batch control, and 2) to determine whether the changes to the 
original immunofluorescence protocol (which were necessary to optimize staining 
and tissue quality for EM) affected dMBP staining. 
The protocol for the best quality immuno-EM is below. Optimal preservation 
of tissue structure, required the following changes for EM versus standard 
histochemistry protocols: lower triton X-100 concentration, post-fix in 4% 
paraformaldehyde and 0.2% glutaraldehyde, and one freeze-thaw cycle instead of 
zero or two. For the samples shown in all figures, cryoprotection in graded sucrose 
solutions was used instead of the glycerol-based cryoprotection described in 
Chapters 2-3. Sucrose cryoprotection was adequate since freezing was only 
required for cryostat sectioning of the small tissue block. Long-term cryostorage of 
the block was not necessary. 
  
77
For sucrose cryoprotection, the small tissue blocks (approximately 3-4 mm3) 
were immersed in a solution of sucrose in 0.1M PBS, starting with a 10% sucrose 
concentration. Once the blocks sank, they were transferred to a 15% sucrose 
solution until they sank, and so forth in intervals of +5% until immersion in 30% 
sucrose.  
Immuno-EM tissue processing: Buffer used for rinses throughout was 0.1M 
phosphate buffer, pH 7.4, and three five-minute rinses were used unless otherwise 
specified. Control tissue sections were processed using the dMBP fluorescent 
protocol alongside the tissue sections for EM, to check the extent to which any 
EM-specific tissue treatments (i.e. glutaraldehyde post-fixation) affected the dMBP 
staining pattern. 
Tissue was rinsed, incubated in 50mM glycine in PB for 1 hour at 4°C, 
rinsed, and incubated in a pre-block solution consisting of 5% BSA (Sigma), 5% 
NGS, and 0.025% EM-TritonX in PB for 1 hour. Tissue was then incubated in 
primary antibody (dMBP, AB5864, Millipore) diluted 1:1000 in PB containing 0.2% 
BSA-c (Aurion), 1% NGS, and 0.025% EM-TritonX. The primary antibody 
incubation took place in the microwave (150 MW setting for 5 minutes, then 2 
minutes at RT, then 5 additional minutes in the microwave at 150 MW) and then 
overnight at 4°C.  
After the overnight incubation (approximately 18-20 hours), tissue was 
washed 3 times for 10 minutes each, and incubated in secondary antibody (anti-
rabbit fab2) diluted 1:100 in PB with 0.2% BSA-c, 1% NGS, 0.025% EM-Tx, and 
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0.1% gelatin (Aurion). The secondary incubation took place in the microwave (150 
MW for 8 minutes) then overnight at 4°C.  
On day 3, tissue was rinsed in PB with 0.2% BSA-c twice for 5 minutes 
each. Tissue was then post-fixed in 3% glutaraldehyde, 2% paraformaldehyde in 
the microwave at 150 MW for 2 minutes. Tissue was then washed in 50mM glycine 
for 5 minutes, then PB at 4°C for two 5 minute rinses. Tissue was incubated in 
20mM sodium citrate buffer, pH7 for 5 minutes, processed with an R-Gent SE-EM 
silver enhancement kit according to the manufacturer’s instructions (with a 45 
minute incubation), rinsed 5 minutes in sodium citrate buffer, and three times in 
PB at 4°C. Tissue was then incubated in a stronger glutaraldehyde fixative (6% 
glutaraldehyde, 2% paraformaldehyde) and microwaved between 150-250 MW in 
2 minute increments until the solution temperature reached 30°C (e.g. 4 times for 
2 minutes each at 150 MW). Tissue was washed three times in PB at 4°C before 
proceeding to EM processing. 
EM processing: tissue was rinsed in PB three times over 20 minutes while 
osmium solutions were prepared. Tissue was then incubated in 1% osmium in the 
microwave (100 MW for 4 minutes in 2 minute intervals), then 10 minutes at RT on 
a rotator. Tissue was then rinsed in PB 4 times to remove osmium, and then 2-3 
times over 1-2 minutes in distilled water. Tissue was then dehydrated in 50% 
ethanol (3 incubations for 5 minutes each), 1% uranyl acetate in 70% ethanol for 
30 minutes, 90% ethanol (3 incubations for 5 minutes each), 95% ethanol (2 
incubations for 5 minutes each) and 100% ethanol (3 incubations for 5 minutes 
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each). Tissue was rinsed in 100% propylene oxide twice over 15 minutes, and then 
infiltrated with araldite. Infiltration was accomplished by incubating tissue in 1:1 
araldite: propylene oxide for one hour, in a capped container, on a rotator. Then 
the incubation continued for an additional hour on the rotator with the container 
uncapped to enable the propylene oxide to evaporate. Tissue was then embedded 
in flat molds in 100% araldite, stored overnight in a dessicator, flat embedded the 
next day, and cured in oven at 60°C for 48 hours. 
Acquisition of Electron Micrographs 
Semithick (1 µm) sections were cut from the Araldite-embedded blocks. 
These sections were mounted on glass slides and stained with toluidine blue to 
determine the surface area of tissue included in each section. Once sufficient 
surface area of the tissue block was exposed, ultrathin sections (50 nm) were cut 
from each block using a diamond knife (Diatome) and an ultramicrotome (Ultracut; 
Leica). Sections were collected on single slot pioloform-coated grids and examined 
at 80 kV using a JEOL JEM 1011 (JEOL) with a digital camera (Gatan). Fields from 
each section were photographed at 10,000x-30,000x magnification. 
Results 
The dMBP fluorescent staining pattern was consistent with labeling myelin 
sheaths and some glia as expected, and minus primary antibody controls were 
always devoid of staining. Results of the dMBP immunofluorescence 
preabsorption control experiment are shown in Figure 11. Higher concentration of 
peptide in the pre-treatment step resulted in less staining by the dMBP antibody. 
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Example electron micrographs are shown in Figure 12. Qualitatively, in EM 
of the corpus callosum, dMBP labeled a proportion of myelin, axons, and glia. It 
did not label artifact “shearing damage.” It sometimes labeled the myelin 
pathologies reported by Peters and colleagues, such as balloons and dense 
inclusions (e.g. Peters & Sethares 2002; Sandell & Peters 2003) but not always. 
Most of the axons that were labeled (in the axoplasm, on the sheath, or both) did 
not have obvious damage. Since most axons were sectioned perpendicularly to 
their long axis, only a fraction of the axon was visible. It is possible that intact-
appearing labeled axons and sheaths were in fact damaged farther along the 
shafts, adjacent to but not within the visible plane of section. 
Discussion 
The preabsorption control and EM were performed to investigate the 
specificity of the dMBP antibody (Aim 2). The fact that preabsorption of the dMBP 
antibody by the dMBP peptide eliminates staining demonstrates that the antibody 
binds to its intended target, and the lack of staining seen in minus-primary controls 
demonstrates that the dMBP antibody is necessary for the label that is observed. 
While the staining pattern revealed by EM was not as straightforward as 
only labeling myelin with evident pathological structure, it did label structures and 
compartments where MBP and/or myelin has been previously localized, for 
example in oligo nuclei (Pedraza et al., 1997), in astrocyte nuclei (Peters & 
Sethares, 2003), on and in astrocytes (Fontana et al., 1984; Peters et al., 1991b; 
Peters & Sethares, 2003; Peters 2009), and in microglia (Peters et al., 1991b; 
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Sandell & Peters, 2002; Peters 2009). Myelin debris has been reported inside 
degenerating axons (Sandell & Peters, 2002), so it is plausible that the label seen 
inside axons in the present study is a valid localization of the dMBP peptide. 
Although many of the labeled axons observed did not have obvious degeneration, 
the dMBP antibody may be sensitive enough to detect myelin fragments that have 
diffused from the site of main damage. The diffusion distance could be small—the 
sections used for EM were 50 nm thick, so damage even a micron away may not 
be visually apparent in the plane of section, but still detectable by antibodies. 
Supporting this concept, the dMBP fragment has been observed in areas where 
axons were still intact, but proximal to areas of Wallerian degeneration (Liu et al., 
2012). 
An additional possibility is that the dMBP fragment is not only an indicator 
of damage and pathology, as the antibody’s creators suggested (Matsuo et al., 
1997 and 1998), but the epitope is also exposed in conditions of remyelination, 
myelin turnover, or for signaling. Many different forms of MBP have been 
implicated in intracellular and intercellular signaling (Harauz et al., 2009). 
Therefore, fragments of MBP could also appear within glia, within axons, or in the 
extracellular space to function as a messaging molecule, whether the message is 
an indication of damage or otherwise. 
Conclusion of Aim 2 
The minus primary antibody control and preabsorption control indicate that 
the dMBP antibody is specific for its target, the “encephalitogenic peptide” 
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sequence of myelin basic protein. The staining pattern obtained with an 
immunofluorescence protocol is consistent with dMBP appearing in expected 
domains. While immuno EM shows dMBP appearing in cell compartments where 
MBP fragments have previously been detected, more experiments are required to 
determine where dMBP fragments appear relative to previously described 
ultrastructural damage (reviewed by Peters & Kemper, 2012), to determine the 
exact conditions under which the dMBP epitope is exposed, and thus to interpret 
the physiological implications of dMBP staining. See Future Directions for 
proposed experiments.  
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Figure 11: dMBP fluorescent preabsorption control 
Corpus callosum of a young monkey (AM299) is shown, stained with dMBP 1:750. 
Antibody was pre-treated with A: no dMBP peptide (standard staining), B: 40x 
molar concentration of peptide, and C: 80x molar concentration of peptide. All 
three images were acquired under the same conditions (300 ms exposure).  
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Figure 12: Immuno electron microscopy of the dMBP antibody 
The dMBP label appears as black particles. A subset of particles are highlighted 
with blue and yellow arrows. A: Several examples of myelin pathologies, some 
labeled by dMBP and some unlabeled. Boxed subfields A1-A3 are magnified at 
right. In the A1 field, there is an unlabeled balloon (i) and an unlabeled dense 
inclusion (ii) around an axon with labeled axoplasm (*). In the A2 field, there is a 
labeled dense inclusion (**). In the A3 subfield, there is an unlabeled dense 
inclusion (***), label on the myelin sheath top right, and label in the axoplasm of 
the axon top center. B: A degenerating axon (X) with dMBP label around the 
perimeter of its myelin sheath. Note that the antibody does not label “shearing 
damage” (#) an artifact of processing. Scale bar = 2 microns in A, 0.5 microns in 
B. 
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CHAPTER FIVE: RELATIONSHIPS BETWEEN HYALURONIC ACID 
HISTOCHEMISTRY, MARKERS OF IMPAIRED REMYELINATION, AND 
COGNITIVE PERFORMANCE IN THE AGING RHESUS MONKEY BRAIN 
Aim 3 Results 
Hyaluronic acid is correlated with myelin damage 
There is a strong positive correlation between HA and dMBP fluorescence 
intensity values in both the CB (entire cohort R2= 0.636, p<0.0001; Figure 13A, C, 
E) and the CC (entire cohort R2= 0.633, p<0.0001; Figure 13B, D, F). The 
relationship between HA and dMBP appears strongest in the cingulum of males, 
where 73.1% of the variability is accounted for by this relationship (R2 =0.731, 
p<0.001, Figure 13C). 
Myelin damage increases with age in the cingulum bundle of male monkeys 
dMBP fluorescence intensity in the cingulum bundle (CB) does not increase 
significantly with age in the entire cohort of 29 subjects (R2=0.111, p=0.077; Figure 
14A). When different sub-cohorts (e.g. males, old monkeys) were analyzed with 
separate single regression analyses, only males showed a significant increase in 
myelin damage in the CB with age (R2=0.359, p=0.030; Figure 14B). Despite the 
limitation of this relationship to males, there was no difference between the sexes 
on dMBP fluorescence intensity assessed by multiple regression (testing 
significance of sex while controlling for age effects; psex= 0.404), t test (p= 0.401; 
not shown), or discriminant function analysis.  
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There were no significant correlations between age and dMBP intensity or 
percent area in female subjects (R2<0.0001, p=0.988; Figure 14C) or old subjects 
(R2= 0.123, p= 0.263; not shown). There were no significant effects of age on 
dMBP staining in the corpus callosum in any group of subjects.  
Hyaluronic acid percent area, but not fluorescence intensity, is positively 
correlated with age in the cingulum bundle 
HA percent area stained increases significantly with age in the CB (R2= 
0.172, p= 0.025; Figure 15A). Despite the strong correlation between the percent 
area and fluorescence intensity measures (Figure 6), the relationship between HA 
fluorescence intensity and age was not significant (Figure 15C).  
Correlations between myelin damage, hyaluronic acid, and cognitive impairment 
index 
When the entire cohort of 29 monkeys was analyzed, dMBP fluorescence 
intensity in the CB correlated significantly with the cognitive impairment index (CII; 
R2= 0.149, p=0.043; Figure 16A). Despite the strong correlation between percent 
area and fluorescence intensity measures (Figure 7), dMBP percent area in the 
CB did not correlate significantly with CII (R2= 0.071, p=0.170; not shown).  
Conversely, HA percent area in the CB correlated significantly with 
increasing CII (R2= 0.164, p=0.032; Figure 15B) but HA fluorescence intensity in 
the CB did not (R2= 0.058, p= 0.219 Figure 15D).  
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The significant relationships between dMBP fluorescence intensity and CII 
and between HA percent area and CII were both strongly influenced by an extreme 
point, the aged male AM121. This subject had a CII much higher than any other 
monkey (12.4, versus the next highest, 6.7. Units are number of standard 
deviations away from the mean performance of young monkeys). In both the dMBP 
and the HA relationship versus CII, the AM121 data point qualified for exclusion 
based on the criteria outlined in Methods. Specifically, it is an outlier (as defined 
by a Studentized residual more extreme than -2 or 2 standard deviations), and it 
is an influential point (as defined by a Cook’s distance value greater than the critical 
value of 4/n), and its exclusion from each graph changed the outcome of the 
regression test from significant to non-significant. Removal of AM121 from the 
dMBP versus CII regression changes the R2 from 0.149 to 0.003 and the p value 
from 0.043 to 0.779 (Figure 16B). Removal of AM121 from the HA versus CII 
regression changes the R2 from 0.164 to 0.014 and the p value from 0.032 to 0.559 
(Figure 16D). Competing rationales for removing versus retaining this outlier, as 
well as interpretations of each regression test outcome, are included in the 
Discussion. 
dMBP fluorescence intensity correlates significantly with cognitive impairment 
index component test scores 
dMBP intensity in the CB correlated positively with subjects’ scores on the 
DNMS acquisition test when the entire cohort was analyzed (R2= 0.190, p= 0.018; 
Figure 16A) and in males only (R2= 0.545, p=0.004; Figure 17B), but not in females 
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(R2= 0.008, p=0.734; Figure 17C). In other words, increased dMBP was positively 
correlated with impaired rule learning, but this effect may be limited to male 
monkeys. 
AM121, the subject that qualified for exclusion in the dMBP versus CII 
regression, also qualified for exclusion in both significant regressions reported 
above: the dMBP versus DNMS acquisition regression for all subjects (Figure 17A) 
and males only (Figure 17B). Removal of AM121 from either regression changed 
the outcome from significant to not significant. Removal of AM121 from the 
regression that included all subjects changed the R2 from 0.190 to 0.048, and the 
p value from 0.018 to 0.265. Removal of AM121 from the regression that analyzed 
only male subjects changed the R2 from 0.545 to 0.298 and the p value from 0.004 
to 0.066. While this result still approaches significance, a second extreme point in 
this relationship also qualifies for exclusion. After removal of this second point, the 
R2 decreases to 0.014 and the p value increases to 0.731. 
dMBP intensity in the CC correlated positively with errors on the DNMS 2 
min test in aged subjects (R2= 0.368, p=0.037; Figure 18A). This relationship is 
significant in males with the removal of an extreme point that qualifies for 
exclusion, the middle-aged male AM288 (R2= 0.689, p=0.001; Figure 18C). The 
relationship between dMBP intensity in the CB and DNMS 2 min test scores was 
not significant. 
A number of relationships between dMBP and CII component tests did not 
attain a p value of <0.05 but did approach significance (0.05< p <0.09). These 
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include the relationship between dMBP intensity in the CB and DNMS acquisition 
in aged subjects only (R2= 0.281, p=0.076; Figure 19A), and dMBP intensity in the 
CC and DNMS acquisition aged subjects (R2= 0.322, p=0.055; Figure 19B) and in 
males (R2= 0.256, p=0.078; Figure 19C). AM121 again qualified for exclusion in 
the relationship between dMBP intensity and DNMS acquisition errors when only 
males were considered (Figure 19C). Removal of AM121 changes the R2 from 
0.256 to 0.236 and the p value from 0.078 to 0.110. 
dMBP fluorescence intensity in the corpus callosum correlates with non-CII 
component behavioral tests  
The delayed response span task for object recognition and memory (DRST 
object) is not a CII component test but is nevertheless interesting as a measure of 
cognitive function. The relationship between dMBP intensity in the CC and DRST 
object, approached significance in aged subjects only (R2= 0.294, p=0.069; Figure 
19D). 
The total number of perseverative errors (Total PE) in the cognitive set shift 
task (CSST) is interpreted as a measure of executive function—higher Total PE 
indicates poorer executive function. The relationship between dMBP intensity in 
the CC and Total PE was not significant when all subjects were analyzed 
(R2=0.006, p=0.721; Figure 20A). However, when sexes were analyzed 
separately, the relationship between dMBP intensity and Total PE in males 
approached a significant positive correlation (R2= 0.277, p=0.065; Figure 20B), but 
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in females this relationship approached a significant negative correlation (R2= 
0.263, p=0.088; Figure 20C).  
Two data points in these regressions qualified for exclusion, one from the 
males only regression and one from the females only regression. Removal of 
AM243, an aged male, from the males only regression changed the outcome from 
approaching a significant increase (R2= 0.277, p=0.065) to not significant 
(R2=0.027, p=0.611). Removal of AM299, a young female, from the females only 
regression changed the outcome from approaching a significant decrease (R2= 
0.263, p=0.088) to a significant decrease (R2=0.397, p=0.038).  
Aim 4 Results 
HA intensity correlates significantly with increased density of oligodendroglia 
precursor cells 
Using simple linear regression, HA fluorescence intensity correlated 
significantly with OPC density in the CB (R2=0.271, p=0.005; Figure 21A). Multiple 
regression analysis yielded a stronger model, which is a quadratic fit that predicts 
OPC density from HA squared, HA, age, and sex (overall R2=0.677, p<0.0001; 
Figure 22A; Table 6). While the linear regression between HA and OPC density in 
the CC was not significant (R2=0.100, p=0.102; Figure 21B), multiple regression 
analysis showed that the relationship between HA in the CC and OPC density was 
significant using a quadratic model that included the variables HA squared, HA, 
and age (overall R2=0.382, p=0.008; Figure 22B; Table 6). 
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The correlation between HA fluorescence intensity and mature oligos in the 
CB was not significant using single regression (R2=0.038, p=0.320; Figure 21C) or 
multiple regression. There was also no correlation between HA and oligo density 
in the CC using linear regression (R2=0.011, p=0.595; Figure 21D). However, 
multiple regression revealed a significant relationship between HA intensity and 
oligo density in the CC, using a quadratic fit that predicts oligo density from the 
independent variables HA squared, HA, age, and sex (overall R2=0.354, p=0.033; 
Figure 22D; Table 6). 
Oligodendroglia precursor cell density, but not mature oligo density, increases 
with age 
The density of oligodendroglia precursor cells (OPCs) increased 
significantly with age in both the cingulum bundle (R2=0.305, p= 0.002; Figure 23A) 
and the corpus callosum (R2= 0.171, p=0.029; Figure 23B). Despite the increase 
in OPCs, the density of mature oligos in the cingulum bundle did not change but 
approached a significant increase (R2=0.112, p=0.082; Figure 23C). If analyzed by 
sexes (Figure 24), oligos do not change with age in females (R2=0.024, p=0.584; 
Figure 24E) but approach a significant increase in males (R2=0.291, p=0.057; 
Figure 24C). Despite the decrease in N when only males are considered (versus 
the entire cohort), the correlation between age and oligo density becomes stronger 
when only males are considered, as judged by both the R2 and p values.  
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In the corpus callosum, the density of mature oligos approached a 
significant decrease with age (R2=0.132, p=0.058; Figure 23D). This relationship 
was not different between the sexes (Figure 24 D and F).  
No significant relationships between OPC density, oligo density, and cognitive 
impairment index 
The correlation between oligo density in the corpus callosum and cognitive 
impairment index (CII) also approached significance, with decreasing oligos 
associated with increased impairment (R2=0.123, p=0.073; Figure 25B). However, 
removal of AM121 rendered the relationship nonsignificant (R2=0.001, p=0.869; 
not shown). There was no correlation between OPC density and CII, or oligo 
density in the cingulum and CII (R2=0.022, p=0.464; Figure 25A). 
dMBP fluorescence intensity correlates with increased OPC density in the 
cingulum bundle 
Fluorescence intensity of the dMBP antibody correlated significantly with 
increased OPC density in the cingulum using linear regression (R2=0.292, p= 
0.003; Figure 26A). Using multiple regression, the best model was a quadratic fit 
that predicted OPC density from dMBP squared, dMBP, age, and sex (overall 
R2=0.697, p<0.0001; Figure 27A). In the CC, the relationship between dMBP and 
OPC density was not significant using single linear regression (R2=0.058, p=0.217; 
Figure 26B). Multiple regression analysis revealed a significant relationship 
between dMBP and OPC density in the CC using a quadratic model that included 
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dMBP squared, dMBP, and age as predictors (overall R2=0.353, p=0.014; Figure 
27B).  
There was no correlation between dMBP fluorescence intensity and oligo 
density in the CB (R2=0.012, p=0.580; Figure 26C) or the CC (R2=0.001, p=0.892; 
Figure 26D). 
Discussion 
Summary of key findings 
Having established that tissue sections from long-term cryostorage using 
our protocol are still of sufficient quality for histochemistry (discussed in Chapter 
2), major findings of the present study include the existence of significant 
correlations between HA and dMBP in all regions and sub-cohorts tested, and 
significant relationships between dMBP and several behavioral measures of 
cognitive function. The correlations between dMBP and cognitive function indicate 
that this marker of myelin damage is relevant to age-related cognitive decline. HA 
staining level is also significantly correlated with increasing oligodendrocyte 
precursor cell (OPC) density in the cingulum bundle, but not with the number of 
mature oligodendroglia (oligos), which is unchanged.  
In the young rodent brain, OPCs proliferate in response to damage, migrate 
to the site of damage, and then differentiate into mature oligos (Hughes et al., 
2013). Under baseline conditions in the young brain, OPC density should be 
constant because these cells maintain their distribution by self-repulsion (Hughes 
et al., 2013). Oligo density likely increases over time in areas of remyelination or 
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“myelin remodeling” (e.g. Young et al., 2013; Peters & Sethares, 2003; reviewed 
by Wang & Young, 2014), but results from the present study show that OPC 
density increases with age and oligo density stays the same in the CB or may even 
decrease modestly in the CC (only approaches a significant decrease). 
The increase in OPC density and apparently stable oligo density indicates 
that OPCs proliferate in response to damage, but may be arrested at that stage 
and fail to differentiate into mature oligos. This pattern of proliferation without 
differentiation has been observed in several different forms of demyelination 
(spinal cord injury, inflammatory demyelination such as multiple sclerosis or EAE, 
and chemical demyelination models) and in some studies has been attributed, at 
least in part, to accumulations of the extracellular matrix glycosaminoglycan 
hyaluronic acid (HA) at the site of damage.  
Since myelin damage increases with age despite the presence of many 
OPCs, it follows that new mature oligos are not being produced in sufficient 
numbers to maintain adequate myelin. The hypothesis of the present study was 
that HA accumulates in white matter regions known to be affected in normal aging 
(cingulum bundle and genu of the corpus callosum) and inhibits remyelination, 
contributing to the age-related increase in myelin damage and cognitive decline. 
Overall, the correlations between HA and markers of impaired remyelination 
examined in the present study— the dMBP marker of myelin damage and 
increased density of OPCs without a concomitant increase in mature oligos— are 
consistent with a hypothesis in which hyaluronic acid accumulation contributes to 
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age-related myelin damage by interfering with repair or maintenance of myelin in 
the aging primate brain. 
Finally, there were several unexpected outcomes of the research presented 
here, particularly related to new methods of quantification. For instance, for HA 
levels, there was a significant linear correlation between the percent area measure 
and the fluorescence intensity measure (Figure 7). Hence, it was surprising that 
the percent area of HA in the cingulum bundle (CB) correlated significantly with 
age but fluorescence intensity of HA did not. Similarly, for dMBP levels, there was 
a significant linear correlation between the percent area measure and fluorescence 
intensity. Yet, for these dMBP measures, fluorescence intensity of dMBP in the CB 
correlated significantly with cognitive impairment index (CII) and rule learning 
errors in the DNMS Acquisition task, but percent area did not. Additionally, it was 
not expected that other correlations were significant in the subgroup of males but 
not for the females. Possible explanations of these unanticipated findings as well 
as other technical considerations are discussed below. 
Technical Considerations 
Consideration of extreme measurements, influential points, and outliers 
As described in Methods, all extreme data points were carefully examined. 
First, the experimental and procedural variables for that subject on that measure 
were examined to be certain that these were not causes that would justify 
exclusion from the study. It is also worth noting that the critical histochemical 
procedures were performed using batch-processing methods, in which all tissue 
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sections are processed in the same reagents for the same amount of time 
throughout the protocol. Every section was exposed to the same settings and 
conditions during storage and image acquisition. Hence extreme values may have 
a good biological basis but nevertheless can distort the analysis. 
To avoid any distortions, an extreme points was excluded from a regression 
if it was both an outlier (as defined by an extreme Studentized residual; Cook & 
Weisberg, 1982) and an influential point (as defined by an extreme Cook’s 
distance; Cook & Weisberg, 1982; Bollen & Jackman, 1990), and if its removal 
changed the outcome of the regression test from significant to non-significant or 
vice versa. Because the appearance of extreme points is specific to each 
regression relationship being analyzed, a point that was excluded from one 
regression analysis was not automatically excluded from the entire study. 
Of particular interest is one aged male, AM121, that was extreme on several 
measures. For example, on the correlation between percent area HA and CII, 
AM121 has a high CII (CII=12.4), which was assessed by the expert administrator 
of behavioral tests as genuine cognitive impairment, and not due to testing 
abnormalities or lack of subject motivation. The degree of impairment is plausible 
since, at 30.2 years of age (equivalent to about a 90 year old human), AM121 is 
the oldest monkey in this study, and approaching the oldest range of the rhesus 
monkey population. Since the tissue from this subject was in good condition and 
since batch-processing methods were used during staining and image acquisition 
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and analysis, there were no known methodological explanations for the extreme 
measurements.  
The next most impaired monkey in the present study had a CII score of 6.7. 
Since no other subjects had a CII score between 12.4 and 6.7, it is unknown 
whether other extremely impaired monkeys would also have high HA staining 
levels. It is possible that other subjects with CII in this range would fill the gap that 
currently exists in the data between AM121 and the majority of subjects, revealing 
a relationship between the two variables in the most impaired monkeys. However, 
with the data at present, the interpretation that most accurately describes the 
relationship between HA and CII for the majority of subjects is that there is no 
significant correlation. Removal of AM121 was justified based on the criteria 
described above, so this subject was excluded from analyses of CII as shown in 
Figure 16. 
Discussion of sex differences in dMBP staining 
No sex differences have been reported in studies of age-related myelin 
damage in monkey brain using diffusion tensor imaging (DTI; Makris et al., 2007). 
In an electron microscopy (EM) study, the area of the cingulum bundle was found 
to decrease by 28% in male monkeys, but not change in female monkeys (Bowley 
et al., 2010). The present study found differences between males and females on 
several measures: 1) Fluorescence intensity of dMBP antibody staining in the CB 
increased significantly with age in males but not in females. The lack of change in 
dMBP staining level in females with age was not due to low dMBP levels 
throughout the lifespan, but rather was because of relatively high staining in some 
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female monkeys from all age groups (Figure 14). 2) Oligo density in the CB 
approached a significant increase in males and again did not change in females. 
3) Relationships between dMBP and cognitive tests (DNMS acquisition errors, 
DNMS 2min) reached significance in males but not females. 4) The relationship 
between dMBP and perseverative errors on the CSST approached significance in 
both males and females, but there was a positive correlation in males and a 
negative correlation in females. 
These differences between sexes are not artifacts of statistical methods. 
Neither CII scores nor DNMS acquisition errors were significantly different between 
males and females of this cohort (p=0.629 and p=0.500, respectively) so there 
were no inherent differences in the cognitive abilities of the groups within the 
sample. The N was smaller for males (N=13) than females (N=16), so it is 
theoretically harder for regressions to reach significance in males because the 
lower N provides less statistical power. It is always possible that the results of a 
study are sample-specific, so replication in other cohorts is necessary for 
confirmation of these findings.  
Studies in rodents suggest that oligo turnover and survival are affected by 
sex hormones (Takao et al., 2004; Cerghet et al., 2006). Oligos synthesize 
progesterone (Zwain & Yen, 1999) and although they cannot synthesize estrogen 
(Zwain & Yen, 1999), they express the -estrogen receptor (Zhang et al., 2004). 
Administration of progesterone and estrogen in vitro affect oligo proliferation, 
maturation, and survival (Takao et al., 2004), and castration of male mice 
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increases their oligo proliferation rate to match levels in females (Cerghet et al., 
2006). After the injection of a chemical demyelinating agent into white matter of 
rats, there was no difference in remyelination between young females and males, 
but aged female rats remyelinated more efficiently than aged males (Li et al., 
2006), suggesting an interaction between sex and age for these variables. In a 
different study of mice older than 9 months, females were found to have an 
increased rate of turnover for both oligodendroglia and myelin relative to males 
(Cerghet et al., 2006).  
Since myelin damage increases with age in both female and male monkeys 
(Makris et al., 2007; Bowley et al., 2010), the finding that dMBP did not increase 
with age in females may be an indication that the dMBP epitope is exposed in 
conditions other than frank myelin damage. This is supported by the observations 
that females show staining throughout the life span (before the increase in myelin 
damage occurs as shown by other methods), the dMBP epitope was seen in nuclei 
and axoplasm using EM (perhaps an indication of function as a signaling molecule; 
Nagasato et al., 1997; Pedraza et al., 1997; Harauz et al., 2009; Liu et al., 2012), 
and the positive correlation between dMBP and total perseverative errors on the 
CSST in males but negative correlation between these variables in females.  
Based on these considerations, one possibility is that the dMBP epitope is 
exposed and labeled in myelin that is undergoing healthy turnover which might be 
greater in females than males, increasing label in the young females. If this is the 
case, overall dMBP staining would not necessarily change with age because 
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healthy remyelination could be decreasing in females while age-related damage is 
increasing. Perhaps the fact that dMBP in the cingulum bundle increased 
significantly in males with age, but not females, indicates that a greater proportion 
of dMBP labeling in males reflects damaged myelin, but that the higher incidence 
of myelin in transition states confounds the quantification of damaged myelin in 
females. This is consistent with the reports of sex differences in myelin dynamics 
of rodents (Cerghet et al., 2006; Li et al., 2006). If the finding that female rodents 
have increased oligo turnover rates is also true in monkeys, and if dMBP is 
exposed in remyelination, these concepts together could provide an explanation 
for the different age-dMBP relationship between the sexes and the relatively high 
staining in young females. 
Comparison of results derived from percent area versus fluorescence intensity 
measures 
Fluorescent staining of HA and dMBP was quantified using two measures, 
percent area and fluorescence intensity. Although these measures were tightly 
correlated to each other (Figure 6), percent area of HA in the cingulum correlated 
significantly with age while intensity did not. Similarly, percent area of HA in the 
cingulum correlated significantly with CII while intensity did not. The opposite 
pattern was true for dMBP staining, with the intensity measure producing more 
significant relationships than the percent area measure.  
These differences could reflect the amount of variability inherent in each of 
the measures. Percent area reduces the information in each pixel to a binary—
black or white, stained or unstained. In contrast, the fluorescence intensity 
  
102
measure quantified the number of pixels that fell into one of six brightness 
categories, and calculated essentially a weighted average intensity for the image. 
This latter measure was designed to keep more of the original image information 
and thus take more variability into account. Examination of variance suggests this 
was the case as the variance of the HA percent area in the CB was 19.9, and that 
of the fluorescence intensity scores was 39.5. Since the percent area measure has 
less variance, and a smaller variance makes it easier to detect a relatively small 
effect size, it follows that a subtle but significant relationship between HA and age 
was easier to detect with the percent area measure. However, this was not the 
case with dMBP, as more relationships between dMBP and other variables 
reached significance using the fluorescence intensity measure of dMBP. 
An alternative to the variance-based explanation is that the percent area 
and fluorescence intensity measures each reflect different information on a 
biological level. The advantage to having a measure that preserves more 
information from the original image is that this information may provide insights 
into more specific localization and thus function. For instance, it could be the case 
that HA, as an extracellular molecule not confined to a cellular compartment, 
accumulates in aging brains by increasing the area it occupies but does not 
accumulate at higher density that would be reflected only in the intensity measure. 
This might be due to structural constraints of the HA scaffold. This would result in 
an increase in area stained but not necessarily in the intensity of staining.  
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In contrast, measures of the dMBP antibody might not follow this pattern 
since its localization is constrained to the myelin sheath compartment and perhaps 
to intracellular compartments within some glia. Thus dMBP might increase in 
intensity of staining (i.e., the amount of damage detectable in the same 
compartment) as more of the myelin at a given locus opened to expose the dMBP 
epitope. This does not preclude increases in the area as the damage appears in 
other internodes of myelin with age but this might occur more slowly than a 
localized increase. The fact that there were cases of dMBP staining reaching 
significance with the fluorescence intensity measure but not percent area (versus 
CII, DNMS acquisition) lends some support to the possibility that each measure is 
representative of different biological information. 
HA as a “damage-associated molecular pattern” and inhibitor of remyelination 
HA has been shown to impair remyelination in several models of myelin 
damage conditions. In brief, increased HA is present in demyelinated lesions in 
multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE, a 
multiple sclerosis model; Back et al., 2005). Demyelination induced by lysolecithin 
injection remyelinates significantly more slowly if HA is co-injected with the 
lysolecithin (Back et al., 2005; Sloane et al., 2010). Hyaluronidase digestion of HA 
in astrocyte-OPC co-cultures leads to increased OPC differentiation into mature 
oligodendroglia, whereas the addition of exogenous HA to OPC cultures inhibits 
differentiation (Back et al., 2005). In vitro, HA inhibits the differentiation of OPCs 
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into mature oligodendroglia through MyD88-mediated TLR2 signaling (Sloane et 
al., 2010). 
From a functional standpoint, HA-mediated inhibition of cell proliferation 
could serve several purposes. Astrocytes produce HA via membrane-bound 
hyaluronic acid synthases, and HA production increases during reactive 
astrogliosis (Back et al., 2005; Struve et al., 2005; Cargill et al., 2012). HA provides 
negative feedback regulation of astrocyte proliferation (Struve et al., 2005), so the 
HA accumulation that results from astrogliosis prevents astrocyte numbers from 
increasing indefinitely, and thus protects tissue from the eventually deleterious 
effects of prolonged or severe astrogliosis (reviewed by Sofroneiw & Vinters, 
2010). Evidence for HA-mediated negative feedback regulation of astrogliosis has 
been reported in CNS injury, ischemia, and inflammatory demyelination models 
(reviewed by Sherman & Back, 2008 and Kohama et al., 2011).  
In addition to HA’s putative role as an astrogliosis regulator, HA fragments 
act as endogenous signals of tissue damage, known as danger associated 
molecular patterns, or DAMPs. Briefly, DAMPs are self-derived biomolecule 
fragments which are recognized by well-conserved pattern recognition receptors 
as a sign that tissue damage has occurred. DAMP signaling evokes an 
inflammatory response (reviewed by Schaefer 2014). Since tissue damage often 
involves extracellular matrix degradation, specific sizes of hyaluronic acid 
fragments can function as DAMPs (reviewed by Jiang et al., 2007; Schaefer et al., 
2014).  
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In the aging brain, HA could accumulate at sites of myelin damage for 
several reasons, likely related to a local increase in HA synthesis by astrocytes 
and/or increased degradation of high molecular weight HA into low molecular 
weight fragments which are insufficiently cleared by microglia and astrocytes. For 
example: 1) astrocytes at the site have become reactive in response to the myelin 
damage and other inflammatory stimuli, causing them to upregulate HA synthesis 
and secretion (Back et al., 2005; Struve et al., 2005; Cargill et al., 2012; reviewed 
by Sherman & Back, 2008 and Kohama et al., 2011); 2) the pre-existing ECM is 
damaged by the same unknown factors that damaged the myelin originally, such 
as oxidative stress (shown to degrade high molecular weight HA into smaller 
fragments; Greenwald & Moy, 1980); or 3) OPCs and astrocytes that are recruited 
to sites of myelin damage may digest the HA-based ECM, to facilitate migration or 
axonal contact. For example, OPCs and astrocytes express the hyaluronidase 
PH20, and fragments produced by this hyaluronidase have been shown to inhibit 
OPC differentiation in vivo in mice (Preston et al., 2013). Since OPCs and 
astrocytes must both migrate through the HA-based ECM to sites of injury, it is 
possible (though undemonstrated) that PH20 facilitates their movement. Using 
HABP as a probe, electron microscopy has shown HA to be associated with 
unmyelinated axons in the rat (Eggli, 1996). Since premyelinating oligos (at the 
O4+ stage) express PH20 at the tips of their processes (Preston et al., 2013), 
perhaps PH20 is used to facilitate axon contact prior to myelination. Thus, while 
reactive astrocytes may produce HA as a protective barrier and/or tissue damage 
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signal, OPCs may express PH20 to facilitate migration. Then once the HA 
fragments resulting from migration have been cleared, OPCs differentiate into O4+ 
premyelinating oligos, which then express PH20 on their processes to break 
through any remaining HA on their way to the axon. Theoretically the fragments 
resulting from the PH20 activity of premyelinating oligos, could, if they reached a 
threshold level, assist in preventing additional OPCs from differentiating and 
redundantly attempting to myelinate the axon in the same area. 
In any of the above scenarios, accumulation of HA would signify that 
astrogliosis and/or the debris-clearing processes were still underway. If OPCs 
detect a threshold level of HA still in the microenvironment of the damaged area to 
which they had been recruited, it could be interpreted by the OPCs as a sign that 
it is not yet productive to differentiate into mature oligos and initiate remyelination. 
Remyelination is accomplished by newly-generated oligos (e.g. Koenning 
et al., 2012; Rivers et al., 2008), which are especially vulnerable to oxidative 
damage (Back et al., 2002a). If OPCs differentiate into oligos before damaged 
myelin and tissue debris are cleared away, the axon may not be accessible or 
ready to be myelinated, and the new oligos could miss the brief window in which 
they are primed to contact the axon to initiate myelination, or could be damaged 
by the inflammatory environment. Generally, oligos begin myelination soon after 
they are created, and once they initiate myelin formation they only have a brief 
window in which to establish all myelin segments that they will ever form (reviewed 
by Mitew et al., 2014). In the developing rodent brain, oligos that do not myelinate 
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undergo apoptosis (Barres et al., 1992; Trapp et al., 1997). Zebrafish oligos in vivo 
must myelinate within 5 hours or undergo apoptosis (Czopka et al., 2013). While 
some new oligos in the developing human brain may be able to wait for several 
months before myelinating (Back et al., 2002b), it is unknown whether any newly 
generated oligos in the adult brain would have this temporal flexibility even if this 
is the case in the embryonic brain. The capacity of new oligos to myelinate in vitro 
also decreases the longer an oligo waits after its creation (Watkins et al., 2008). 
Furthermore, because myelin contains a high proportion of easily oxidized 
polyunsaturated fatty acids, it is especially vulnerable to oxidative damage (Reiter, 
1995; McCracken et al., 2000). Premyelinating oligos have been demonstrated to 
be especially vulnerable to ischemic stress and oxidative damage (Back et al., 
2002a). Therefore, oligos that are generated before the hazardous pro-
inflammatory environment is resolved would be at great risk for damaging any 
myelin they create before the sheath is even complete, jeopardizing the sheath’s 
structure and strength. HA may function as an indicator of tissue damage, inhibiting 
differentiation of OPCs before the environment is conducive to remyelination in 
order to prevent wasting the reparative potential of OPCs that are successfully 
recruited. 
Differences between findings in the cingulum bundle versus corpus callosum 
There were a number of key differences in results observed in the CB and 
CC including:  1) HA percent area increased significantly with age in the CB but 
not the CC.  2) dMBP intensity and oligo density both increased in the CB of males 
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with age, but not in the CC. In all subjects, oligo density approached a significant 
increase in the CB with age but approached a significant decrease in the CC with 
age. 3) Relationships between dMBP and measures of cognitive decline often 
reached significance for dMBP staining in one region or the other, but not both.  
The most likely explanations for these findings pertain to:  1) Differences in 
cellular composition between the two regions;  2) Differences in OPC recruitment 
and migration capability between the regions;  3) Possible difference in how 
impairments manifest in each region because of their different connections and 
functions. 
There are different proportions of the three main glial subtypes (astrocytes, 
microglia, and oligodendrocytes) in different regions. In EM studies, OPCs were 
referred to as “beta-astrocytes” before being recognized as a distinct cell type in 
2004, due to their morphological similarities with astrocytes (Peters, 2004). They 
were not quantified as their own subtype in the pre-2004 studies by Peters that 
quantified proportions of glial subtypes. It is possible that some OPCs were 
included in astrocyte counts, so these numbers should be interpreted with caution. 
Moreover, there is no data regarding glia proportions of glial subtypes for many 
key white matter regions, including the CC and CB. However, some available 
examples of differences in proportions of glial subtypes between regions, as 
reviewed by Peters and Sethares (Peters & Sethares, 2004) are as follows: the 
anterior commissure has 86% oligos, 9% astrocytes, and 5% microglia (Sandell & 
Peters, 2003); the optic nerve has 59% oligos, 35% astrocytes, and 7% microglia 
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(Sandell & Peters, 2002). Within area 17, the layer that has the highest proportion 
of oligos is layer 4Cb with 63% oligos, 30% astrocytes, and 7% microglia (Peters 
et al., 2008). Peters and Sethares (2004) note that in general, areas with higher 
proportioins of myelinated fibers have higher proportions of oligos which is 
reasonable since oligos are needed to maintain myelin.  
In some areas, the proportions of glia change with age. For instance, in the 
visual cortex layer 4Cb, Peters reports an increase in the number of oligos with 
age, resulting in oligos becoming 70% of all glia (Peters et al., 2008). In contrast, 
the proportion of glial subtypes does not change in the anterior commissure, but in 
this region nerve fibers are lost (Sandell & Peters, 2003). Since astrocytes and 
microglia both affect oligo and OPC function (reviewed by Fields et al., 2015) 
different relative numbers of these cell types between the CB and CC could be 
responsible for the different results obtained in the present study.  
Importantly, in addition to different proportions of glial subtypes, the cells 
may behave differently in different regions. For example, astrocytes were shown 
to hypertrophy with age in the CB but not CC (Sloane et al., 2000; Bowley 2007), 
which is relevant because astrocytes increase their secretion of HA when they 
become reactive. Astrocyte density increased with age in the CB but not the CC 
(Bowley 2007) Astrocyte status is especially relevant to the present study because 
astrocytes are the primary source of HA in white matter. The differences between 
regions could be due to a higher level of HA in the CB than in the CC, resulting 
from the greater density of astrocytes and higher level of astrocyte activation. If 
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there is a threshold of HA accumulation at which OPCs start being affected, 
perhaps the CB reaches this threshold earlier or more easily than the CC. The 
absolute levels of HA in each region were not quantified in this study because the 
microscopy methods necessitated analyzing each image using thresholds that 
were specific for its dynamic range of staining. Since relative thresholds were used 
within each region of interest, the two regions were not be directly compared. 
ELISA-based assays are a more direct method of comparing HA between regions, 
and could be used for future studies.  
The second possible explanation for the discrepancies found between ROIs 
in this study is that differences in the extracellular structure and tissue composition 
may affect OPC recruitment and migration. For example, one discrepancy was that 
HA correlated with increased OPC density in the CB, but not in the CC. This could 
be because the CC is much larger, with dense fiber structure relative to the CB, in 
which fibers travel in more varied directions and there is a higher density of 
astrocytes. Perhaps OPC mobility is more limited in the CC due to its size and fiber 
density, making it more difficult for OPCs to be recruited to sites of damage. This 
could result in a lack of correlation between HA and OPCs, or dMBP and OPCs, 
despite the fact that OPCs increase significantly with age. 
The possibility of OPC recruitment being altered in normal aging is 
supported by reports that OPC recruitment to areas of experimentally damaged 
myelin is impaired in aged rats (Sim et al., 2002; Chari et al., 2003). Furthermore, 
in the CB in the present study, OPC density correlates strongly with dMBP in young 
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monkeys but the correlation is weak in old monkeys, possibly indicating that OPCs 
do not migrate to sites of damage as efficiently in aged monkeys. 
Quantifying changes in oligo density with age: resolving differences between 
findings from this study and previous work  
Previous studies have reported age-related changes in mature oligo density 
including a 50% increase in oligo density in Area 17 (Peters et al., 2008), a 45% 
increase in Area 46 (Sandell & Peters, 2002), and a 20% increase in the fornix 
(Peters et al., 2010). However, there was no change in oligo density in the anterior 
commissure (Sandell & Peters, 2003). Overall this suggests that different regions 
vary in whether or not they manifest an increase in oligo density and if they do, the 
degree of increase.  
In the present study, oligo density approached a significant increase in the 
CB, while in the CC it approached a significant decrease with age. This was 
surprising as findings from previous studies (Bowley 2007) found an increase in 
oligos with age in the CB, and no change in oligo density with age in the CC. This 
appears to be in conflict to the findings of the present study. However, the 
discrepancy is likely due to methodological differences. The previous studies 
quantified oligos by counting their nuclei using EM, whereas the present study 
counted as oligos cells that were positive for the immunohistochemical marker 
CC1 (Brakeman et al., 1999). This is a relevant distinction because dysfunctional 
oligos are capable of losing their CC1+ status without undergoing apoptosis 
(Koenning et al., 2012). Furthermore, another study showed a reduction in oligo 
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and myelin immunohistochemical markers with age, specifically a decrease in the 
oligo marker CA II in aged rodents (Cerghet et al., 2006). The authors dismissed 
the finding as a technical shortcoming: “The reduction in the number of CA II+ cells 
in older animals is likely technical, because we found less penetration of Olg [oligo] 
and myelin antibodies in aged animals, and white matter immunostaining is less 
consistent in the older animals” (Cerghet et al., 2006, p. 1442). In other words, they 
observed differences in myelin and oligo markers in aged animals but assumed 
they were artifacts and did not pursue them.  
Therefore, it is possible that differences between the present study and 
previous studies could be explained by methods. The present study counted the 
subset of oligos that were still functional enough to express myelin markers, 
whereas the EM studies (Bowley 2007; Bowley et al., 2010) counted the total 
number of oligos regardless of their myelinating status.  
Remyelination is performed by newly generated oligodendroglia, but little is 
known about the process by which old oligos are replaced by new ones. It is 
unknown whether old oligos undergo apoptosis in order to be replaced by a new 
cell, or if an oligo continues to maintain its functional internodes even as its 
damaged ones are cleared away. Since oligos are capable of maintaining many 
internodes across multiple axons, it would be unlikely for damage confined to a 
small number of internodes to cause apoptosis of the entire oligo, and thus loss of 
an intact majority of internodes. The latter possibility would facilitate the outcome 
in which oligos gradually produce less and less myelin, but do not die. This would 
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be a function-based reason for oligo cell programming to activate compensatory 
changes that enable its survival, even possibly at the expense of myelin 
maintenance and/or production. If combined with an environment in which debris 
clearance is slowed (Njie et al., 2012; Ritzel et al., 2015) and fewer newly 
generated oligos are available for support, the quality of myelin produced and the 
effectiveness of myelin maintenance could gradually decrease over time.  
Because myelin is made from the oligo cell membrane, unrepaired myelin 
damage in the aging brain can be regarded as indicative of an injured oligo. 
Theoretically, for mild damage, the oligo repairs myelin damage via repair and 
maintenance of its own cell membrane. There is much evidence that oligos must 
actively maintain the materials of their myelin sheaths, even after initial myelination 
(e.g. Lajtha et al., 1977; Kramer et al., 2001; Ando et al., 2003; Koenning et al., 
2012). If the rate or severity of damage increases, or if the rate of oligo replacement 
slows, theoretically there is a threshold point of damage at which the injured oligo 
must either: 1) undergo apoptosis, facilitating remyelination by a new oligo (if 
available), or 2) make compensatory changes in an attempt to survive despite 
cellular stress. Downregulating expression of myelin genes (and thus losing 
markers such as CC1 and CAII) could be a compensatory survival mechanism.  
In the aged brain it could be the case that dysfunctional oligos do not die 
but survive as they attempt to maintain signal propagation and metabolic stability 
of the axons they ensheath. Then, living as dysfunctional cells, they could send 
inappropriate signals to the other glia that are trying to facilitate the repair of myelin 
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damage, for example by clearing myelin debris. It is unknown whether the 
presence of old oligos affects the generation of new ones. 
Although neurons are not lost in the normal aging brain, axons are lost. The 
proportion of myelinated axons lost in the oldest animals was reported to approach 
1% in the genu of the corpus callosum and the cingulum bundle (Bowley et al., 
2010). The loss of axons without loss of neurons is hypothesized to be a 
downstream effect of myelin damage: myelin damage results in altered saltatory 
conduction, impairment in action potential propagation, dysfunctional or unreliable 
signaling, and ultimately a decrease in trophic support from the projecting axon’s 
target (Peters & Rosene, 2003; Bowley et al., 2010; Kohama et al., 2012). The 
lower level of trophic support is insufficient to sustain the projecting axon, which 
then degenerates. The neuron, however, can rely on its many other local 
connections for trophic support, so it survives despite the degeneration of its long 
projecting axon (Peters & Rosene, 2003; Bowley et al., 2010; Kohama et al., 2012). 
Myelin supports axon health in other ways as well, such as forming a 
physical barrier between the axon and any damaging factors in the 
microenvironment, and providing metabolic support from oligos to the axon (e.g. 
Lee et al., 2012; reviewed by Fields et al., 2015). Therefore, in addition to the 
above model, axons may degenerate not only from lack of trophic support, but also 
because of exposure to oxidative stress and inflammation as the protective 
ensheathment of myelin is compromised and/or from a loss of metabolic support 
when oligos become dysfunctional or deformed. 
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To this point, it is interesting that the percentage of nerve fibers lost with 
age is high in anterior commissure, where there is not a reported increase in oligos 
(45% loss of fibers in anterior commissure, versus 30% fibers lost in fornix). This 
could be interpreted as an implication that a greater number of oligos is needed to 
maintain axons in the aged brain. Or, if oligo numbers increase because 
dysfunctional oligos do not die even though they are being functionally replaced, 
the increase in oligo numbers could be necessary for preservation of nerve fibers 
because it is an indication that new oligos are being produced and myelin 
maintenance is occurring successfully. 
Relationships between histochemical markers and measures of cognitive decline 
There were many more significant correlations between dMBP and 
behavioral test scores than HA and behavioral test scores. The only significant 
relationship between HA and a measure of cognitive decline was the correlation 
between HA percent area and cognitive impairment index (r=0.405, R2=0.164, 
p=0.032). The significance of this correlation was not supported by the relationship 
between HA fluorescence intensity and CII, which was not significant (r=0.241, 
R2=0.058, p=0.219). As discussed above, this may be because fluorescence 
intensity and percent area capture different biological information from images. It 
likely also indicates that HA levels in the two regions examined do not have a direct 
effect on cognition. Nevertheless, because dMBP staining in the regions of interest 
examined did correlate significantly with several measures of cognition, it is 
evidently a more sensitive histochemical correlate of cognitive status than HA.  
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There were significant correlations between dMBP fluorescence intensity in 
the CB and: CII, DNMS acquisition in all subjects, and DNMS acquisition in males 
only. Fluorescence intensity of dMBP in the CB also approached a significant 
correlation with DNMS acquisition in aged subjects only.  
Despite dMBP increasing with age only in the cingulum bundle of males, a 
number of correlations between cognitive test scores and dMBP staining were 
significant in the CC but not the CB. Fluorescence intensity of dMBP in the CC 
correlated positively with errors on the DNMS 2 min test in aged subjects and in 
males (with the removal of an outlier). Many correlations approached significance 
(0.05< p <0.09), including relationships between dMBP intensity in the CC and: 
DNMS acquisition aged subjects, DNMS acquisition in males, and DRST object in 
aged subjects. The fact that cognitive tests correlated more strongly to staining in 
the CC, despite correlations with age being stronger in the CB, may indicate that 
dMBP staining in the CC serves as a more general marker of white matter damage 
throughout the brain. Since the CC is not directly implicated in the cognitive 
functions measured by these behavioral tests, damage in the CC may reflect 
widespread, general damage, including damage in temporal lobe structures critical 
for cognitive function. 
Interestingly, the relationship between dMBP intensity in the CC and Total 
PE on the CSST was not significant when all subjects were analyzed, but when 
males and females were analyzed separately, the relationship between dMBP 
intensity and Total PE in males approached a significant positive correlation (R2= 
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0.277, p=0.065; Figure 19B), but in females approached a significant negative 
correlation (R2= 0.263, p=0.088; Figure 19C). In other words, increased dMBP 
staining in males is associated with a higher number of total perseverative errors 
(worse performance in the cognitive set shifting task of executive function), 
whereas increased dMBP staining in females is associated with a lower number of 
total perseverative errors (better performance). This finding may be another 
indication that 1) the dMBP epitope is exposed during healthy remyelination as 
well as myelin damage, and 2) that the baseline rate of remyelination is higher in 
females than in males in the monkey as well as in rodents. If so, dMBP may be a 
more reliable marker of myelin damage in male subjects, because dMBP staining 
is more likely to be confounded by the higher rate of healthy myelin turnover in 
female subjects. 
Conclusions: Potential physiological role of HA in the age-related increase 
in myelin damage, and relevance of findings to previous models of 
cognitive aging 
The significant correlations between HA and markers of impaired 
remyelination are consistent with the hypothesis that HA contributes to age-related 
white matter damage by inhibiting the differentiation of oligodendroglia precursor 
cells (OPCs) into mature oligodendroglia (oligos) capable of myelin repair. These 
findings are further supported by the correlations between the various 
histochemical markers and behavioral measures of cognitive impairment.  
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Previous hypothetical explanations of cognitive impairment in normal aging 
have attributed decline mainly to decreased connectivity between neurons due to 
accumulating myelin damage (e.g. Peters & Rosene, 2003; Kohama et al., 2012). 
Although the initial causes of the myelin damage are not known, many suspected 
causes were age-related increases in damaging factors in the brain such as 
increased inflammation, hypoxia, ischemic stress, and oxidative damage. The 
present study adds to this model by describing relationships between the myelin 
damage and factors like HA that could interfere with myelin maintenance and 
repair (e.g. Sloane et al., 2010). While the experiments described here do not 
prove a causal relationship between HA and myelin damage, they provide 
justification for adding HA accumulation and remyelination impairment to the list of 
factors that are suspected to contribute to the age-related increase in myelin 
damage and which should be considered in developing experimental interventions. 
Figure 27 illustrates a hypothetical sequence of events that show how 
accumulation of HA and impaired remyelination could contribute to age-related 
myelin damage and cognitive decline. Figure 28 is a simplified diagram which 
illustrates a hypothesis as to why the brain might have a mechanism for inhibiting 
or postponing myelin repair. These steps are explained in greater detail throughout 
the introduction and discussion. To summarize: Mature oligos must actively 
maintain their myelin sheaths once they have been produced (Lajtha et al., 1977; 
Kramer et al., 2001; Ando et al., 2003; Koenning et al., 2012), and in the CNS 
oligos maintain many internodes on the same or different axons (e.g. Back et al., 
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2002b). At some point in the aging process, whether through exposure to 
damaging factors such as oxygen free radicals or through intrinsic cellular 
changes, oligos are unable to repair or maintain a subset of their internodes. While 
the cause of this initial myelin damage is unknown, possibilities include some 
combination of increased oxidative stress (Mendoza-Nunez et al., 2007), 
epigenetic changes (Shen et al., 2008; Copray et al., 2009), increased astrogliosis 
(Sloane et al., 2000), and/or increased inflammation (Blasko et al., 2004).  
The age-related accumulation of myelin damage could be due to the above 
intrinsic and damaging factors, but the changes in HA, dMBP, and density of oligo 
lineage cells reported in the present study are consistent with the possibility that 
the myelin maintenance process is disrupted with age as well. Much remains 
unclear about the myelin maintenance process, but in the continued investigation 
of myelin maintenance in the aging brain, three big-picture unknowns are critical: 
1) The threshold at which a myelin internode becomes sufficiently damaged that it 
cannot be maintained/repaired by the oligo itself, and must be cleared as tissue 
debris by phagocytic cells (as well as the molecular signal(s) for this transition from 
“self” to “debris”);  2) For an individual oligo, the threshold number of degenerating 
internodes at which it is more efficient for the oligo to undergo apoptosis and be 
replaced (as opposed to surviving to maintain its intact internodes and allowing its 
damaged ones to be cleared and remyelinated by new oligos) and whether this 
threshold changes with age; and  3) The degree to which inefficient clearance of 
myelin damage and other tissue debris interferes with the optimal turnover of oligos 
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and healthy remyelination. For example (Figure 28), an axon cannot be 
remyelinated if the old damaged myelin is still present, and ongoing inflammation 
presents dangers to vulnerable premyelinating oligos (Back et al., 2002a) and new 
myelin structures (Reiter, 1995).  
It is not known whether an oligo can lose one or a few myelinating processes 
and still survive to maintain the majority of its other internodes; however, if an oligo 
underwent apoptosis every time it lost one internode, a very small insult could have 
widespread consequences for myelin damage. The model proposed here operates 
on the hypothesis that otherwise healthy oligos will stop maintaining internodes 
that have reached a threshold of damage, in order to survive and maintain its other 
internodes. This allows the existing damage to be cleared, while preventing the 
unnecessary degradation of the oligo’s healthy internodes. 
The flowchart in Figure 27 follows two main courses, hinging on whether 
the tissue debris from damaged myelin, apoptotic oligos, and fragments of 
extracellular matrix structures (including HA) are cleared effectively. When myelin 
damage occurs, OPCs proliferate to maintain their numbers, and some migrate to 
the location where remyelination is needed (Hughes et al., 2013). If the damage 
has been cleared in a timely manner, the recruited OPCs will differentiate into 
premyelinating oligos and eventually mature oligos. While changes in myelination 
may cause changes in action potential timing, especially if the number of 
nodes/internodes increases (Pajevic et al., 2014) compensation may be possible 
if timing can be adjusted in other parts of circuits. Moreover, any adjustments to 
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signal timing after remyelination are likely to be minor relative to the adjustments 
that would be necessary if the axon segment were to remain unmyelinated. The 
left side of the Figure 27 flowchart is thus representative of healthy adult 
remyelination. 
If debris is not cleared efficiently, or at all, events are hypothesized to 
proceed as shown on the right side of the Figure 27 flowchart. Increased 
astrogliosis was reported in the regions examined in the present study (Sloane et 
al., 2002), and reactive astrocytes produce HA (reviewed by Sherman & Back, 
2008; Kohama et al., 2012). The present study found that increased HA was 
strongly correlated with the dMBP marker of myelin damage, as well as a higher 
density of OPCs but not a concomitant increase in mature oligos. Previous studies 
have reported an age-related increase in oligos in the CB and no change in the 
CC (Bowley 2007), but because of the differences in oligo markers used, the 
discrepancy could be due to oligos becoming dysfunctional with age, staying alive 
despite losing expression of myelin genes and mature markers. 
The oligos in aged rhesus monkey brains develop cytoplasmic inclusions, 
seen via EM (Peters et al., 1996). The myelin produced and maintained by these 
oligos is often malformed or contains pathologic dense inclusions or balloons that 
form in splits of the intraperiod line (Feldman & Peters, 1998; reviewed by Peters 
& Kemper, 2012 and the Introduction). These observations may be one indication 
that, in the aged brain, oligos survive long after they cease to be healthy, functional 
cells. Whether this is due to an inability to be replaced or due to inappropriate pro-
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survival mechanisms (analogous to a cancer cell) is unknown. Oligos may not be 
the only glia cell that experiences this dilemma with age—the increased number 
of inclusions in microglia, and reports of microglia in aged brains not functioning 
as well as those of young brains (Njie et al., 2012; Ritzel et al., 2015) may indicate 
that microglia are not functional (or replaced) enough in the aged brain to maintain 
homeostasis. The theoretical steps in Figures 27 and 28 are consistent with 
previously reported age-related changes, but many causal relationships are yet to 
be tested experimentally, especially in primate white matter. 
Future Directions 
Additional studies are needed to further investigate the rate of remyelination 
and oligo turnover in adult primate white matter. For instance, the rate of oligo 
apoptosis in the adult and aging brain remains to be determined. This could be 
investigated using double label immunohistochemistry (IHC) of a reliable marker 
of mature oligos with an apoptosis marker such as anti-caspase 3. Since studies 
in rodents have found sex differences in the rate of oligo turnover (Cerghet et al., 
2006), the study of oligo apoptosis in monkeys should determine whether there is 
a sex difference in primates as well.  
It has been previously shown that mature oligos can lose myelinating status 
and markers of maturity (CC1) without undergoing apoptosis or de-differentiating 
(Koenning et al., 2012). It is unknown whether oligos in aged monkeys can lose 
the ability to maintain myelin but still survive, and it is unknown whether oligos in 
the monkey lose the CC1 marker with age. This could be tested using an 
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immunohistochemical (IHC) double label of CC1 and a specific oligo marker that 
is not affected by age. A paper by Ness and colleagues (Ness et al., 2005) reviews 
options of IHC labels for oligos, and many papers (e.g. Duce et al., 2008; Koenning 
et al., 2012) offer insights as to which markers may be affected by age and/or oligo 
dysfunction. Because CC1 is a commonly used oligo marker, it is important to 
know if it does not detect all oligos with age so more reliable oligo markers can be 
substituted in studies with aged subjects. 
If oligos do lose their CC1+ status with age, it must be determined whether 
there are morphological differences between CC1+ and CC1- oligos that are 
visible by light microscopy, and whether CC1- oligos are more likely to show 
ultrastructural damage or inclusions via EM. 
Myelin gene regulatory factor (MRF) is a genetic “switch” for the expression 
of genes necessary for the production of myelin components, and may be useful 
as a marker of active myelination (Koenning et al., 2012; Bujalka et al., 2013). It is 
unknown whether MRF expression is altered in oligos in the normal aging brain. 
Determining whether the number and proportion of MRF- oligos changes with age 
could function as a supplementary approach to the CC1 study described above, to 
investigate whether oligos may lose their mature myelinating phenotype without 
dying. A change in the proportion of CC1+ oligos is suspected in the cingulum 
bundle and corpus callosum with age because the present study did not find the 
increases in oligos reported by Bowley (Bowley 2007) who counted oligos by their 
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nuclei using EM. However, MRF expression is a more direct marker of mature 
function than CC1, and may be a more sensitive marker as well.  
Future studies are needed to determine whether the dMBP epitope is 
exposed during healthy remyelination as well as in damaged myelin. It is 
technically challenging to create a reliable positive control for “remyelination.” 
Instances of axons being myelinated in the developing rodent brain have been 
shown in EM (Peters et al., 1991a); however, in the aging brain it is difficult to 
reliably differentiate between axons undergoing remyelination (in which the 
cytoplasm-filled “mesaxons” are visible) and axons with mild dense inclusions 
(since these inclusions are filled with the cytoplasm of the ensheathing oligo). 
Immuno-EM with dMBP in the brain of a young monkey still undergoing de novo 
myelination could be attempted, especially if perfused with EM-specific fixatives to 
yield excellent tissue preservation. Alternatively, since Peters and Sethares 
considered the frequency of paranodes to be a marker of remyelination in the adult 
brain (Peters & Sethares, 2003), the frequency of paranodes could be tested for 
correlations with dMBP staining within the same ROIs of the same subjects. Since 
the exposure of the dMBP epitope would theoretically be transient during the 
remyelination process, but the increased frequency of paranodes would be semi-
permanent, there may not be a significant correlation.  
The most direct approach to determining whether the dMBP epitope is 
exposed during remyelination would be to use the strain of mice described by 
Koenning and colleagues (Koenning et al., 2012) in which MRF knockout can be 
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induced in oligodendrocyte lineage cells in the adult brain. Once MRF is knocked 
out, the mice are unable to remyelinate because their oligo lineage cells cannot 
express genes necessary to create new myelin. To determine whether dMBP is 
exposed during remyelination, first a controlled, reproducable area of myelin 
damage should be created by lysolecithin injection in 1) a group of adult MRF KO 
mice, and 2) a control group of mice from the same strain, but in which KO has not 
been induced. Then, after a delay period that is sufficient for partial remyelination, 
the mice can be sacrificed and tissue sections containing the lesion site stained 
for dMBP. If the dMBP epitope is not exposed during remyelination, the Group 2 
control mice should have less dMBP staining than the Group 1 MRF KO mice, 
because the control mice are able of repairing the damage and the KO mice are 
not. However, if the dMBP epitope is exposed during remyelination, the Group 2 
control mice which are capable of remyelination should have dMBP staining that 
is equal to or greater than the dMBP staining in the Group 1 MRF KO mice. (The 
staining could be equal if damaged myelin is cleared away at the same rate as the 
new but exposed myelin is created. The staining would be greater if damaged 
myelin remained present in some form, including within astrocytes or microglia, 
while remyelination was occurring.)  
Finally, the experiments reported here were not designed to detect or 
explain a sex difference. While the results from this study indicate that there may 
be differences between dMBP expression and oligo lineage changes between 
male and female monkeys with age, additional tests are needed to determine 
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whether the sex differences reported here are replicable in other cohorts, and if 
so, which hormones or other biological features underlie them. It is important to 
determine whether sex differences in OPC and/or oligo dynamics exist in rhesus 
monkeys and humans with age as they do in rodents (Cerghet et al., 2006) 
especially because this information would inform the development of therapeutic 
interventions. If there is a sex difference in the remyelination capacity of the aging 
primate brain, any proposed interventions in monkeys or humans would have to 
take into account subjects’ age, sex, and menopausal status. 
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Figure 13: The dMBP marker of myelin damage correlates with HA histochemistry. 
A: dMBP staining versus HA staining in the CB for all subjects. B: dMBP versus 
HA staining in the CC for all subjects. C: dMBP versus HA staining in the CB for 
males only. D: dMBP vs HA staining in the CC for males only. E: dMBP versus HA 
staining in the CB for females only. F: dMBP versus HA staining in the CC for 
females only.  
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Figure 14: Age versus dMBP fluorescence intensity in the cingulum bundle  
Age versus dMBP fluorescence intensity is shown for the cingulum bundle in A: all 
subjects, B: males only, and C: females only.  
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Figure 15: HA percent area, but not fluorescence intensity, increases in the CB with age and CII.  
HA percent area in the CB reaches significance versus age and cognitive 
impairment, but HA fluorescence intensity in the CB does not. A: HA percent area 
versus age. B: HA percent area versus CII. Exclusion of the outlier makes the 
relationship not significant. C: HA fluorescence intensity versus age. D: HA 
fluorescence intensity versus CII. 
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Figure 16: Correlations between dMBP, HA, and CII, with and without AM121 
A: dMBP fluorescence intensity in the CB versus cognitive impairment index (CII) 
scores. B: Removal of the outlier AM121 from the graph in A changes the 
relationship to be not significant. C: HA percent area in the CB versus CII scores. 
D: Removal of the outlier AM121 from the graph in C changes the relationship to 
be not significant.  
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Figure 17: dMBP fluorescence intensity in the cingulum bundle increases with delayed non-match to 
sample (DNMS) acquisition errors  
The dMBP marker of myelin damage in the CB correlates significantly with an 
increased number of errors on the DNMS acquisition test of rule learning in A: all 
subjects, as well as B: males only, but not in C: females. Removal of the most 
extreme point in A and B make the relationships not significant.  
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Figure 18: dMBP intensity in the corpus callosum increases with DNMS errors at a 2- minute delay  
The dMBP marker of myelin damage in the CC correlates significantly with 
increased recognition memory errors in aged subjects (A). There is no correlation 
when males of all ages are considered (B), but if one outlier is removed from B, 
the correlation becomes significant (C).  
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Figure 19: Relationships between dMBP fluorescence intensity and cognitive tests that approach 
significance.  
A: dMBP intensity in the CB and DNMS acquisition errors (measure of rule 
learning) in aged subjects. B: dMBP intensity in the CC and DNMS acquisition 
errors in aged subjects. C: dMBP in the CC and DNMS acquisition errors in males 
only. Removal of either extreme point makes the relationship not significant. D: 
dMBP in the CC and Delayed Response Span Task object scores (measure of 
object recognition memory) in aged subjects.  
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Figure 20: dMBP fluorescence intensity in the CC approaches a significant increase versus total 
perseverative errors in males, but approaches a significant decrease in females 
A: dMBP fluorescence intensity in the CC versus total perseverative errors (PE) in 
all subjects. B: dMBP fluorescence intensity in the CC versus total PE in males 
only. C: dMBP fluorescence intensity in the CC versus total PE in females only. 
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Figure 21: HA fluorescence intensity correlates significantly with increased density of OPCs in the 
cingulum bundle but not in the corpus callosum using single linear regression analysis  
A: HA fluorescence intensity correlates positively with OPC density in the cingulum 
bundle (CB). B: The correlation between HA fluorescence intensity and OPC 
density in the corpus callosum (CC) is not significant. C and D: There is no 
correlation between HA fluorescence intensity and mature oligo density in either 
the CB (C) or the CC (D). 
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Figure 22: HA fluorescence intensity correlates significantly with increased density of OPCs in both 
regions using quadratic multiple regression models  
A: HA fluorescence intensity correlates positively with OPC density in the cingulum 
bundle (CB) using a model that includes HA squared, HA, age, and sex. B: The 
correlation between HA fluorescence intensity and OPC density in the corpus 
callosum (CC) is significant using a multiple regression model that includes HA 
squared, HA, and age. C: There is no correlation between HA fluorescence 
intensity and mature oligo density in the CB. D: There is a significant nonlinear 
relationship between HA and oligo density in the CC using a multiple regression 
model that includes HA squared, HA, age, and sex.  
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Figure 23: OPC density, but not mature oligo density, increases significantly with age 
A: OPC density increases significantly with age in the cingulum bundle. B: OPC 
density increases significantly with age in the corpus callosum. C: There is no 
change in mature oligo density in the cingulum bundle, but it approaches a 
significant increase. D: There is no change in mature oligo density in the corpus 
callosum with age, but it approaches a significant decrease.  
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Figure 24: Relationship between age and oligo density, analyzed by sex 
The relationship between age and oligo density approaches a significant increase 
in the CB when all subjects are considered (A).When males and females are 
analyzed separately, oligo density approaches a significant increase with age in 
males (C) but there is no significant relationship in females (E). The correlations 
between age and oligo density in the CC for each sex group are shown in B: all 
subjects D: males only, and F: females only.  
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Figure 25: Mature oligos versus cognitive impairment index in the cingulum bundle and corpus 
callosum 
A: There is no correlation between mature oligo density and cognitive impairment 
index in the cingulum bundle. B: Mature oligo density in the corpus callosum 
approaches a significant decrease with increasing cognitive impairment. 
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Figure 26: dMBP fluorescence intensity correlates with increased OPC density in the cingulum 
bundle using single linear regression 
A: Increased dMBP fluorescence intensity is positively correlated with OPC density 
in the cingulum bundle. B: There is no significant linear relationship between dMBP 
intensity and OPC density in the corpus callosum. C-D: There is no correlation 
between mature oligo density and dMBP fluorescence intensity in either the 
cingulum bundle (C) or the corpus callosum (D).  
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Figure 27: dMBP fluorescence intensity correlates with increased OPC density in the cingulum 
bundle and corpus callosum using nonlinear multiple regression models 
A: There is a significant nonlinear relationship between dMBP intensity and OPC 
density in the CB using a multiple regression model that includes dMBP squared, 
dMBP, age, and sex. B: There is a significant nonlinear relationship between 
dMBP intensity and OPC density in the CC using a multiple regression model that 
includes dMBP squared, dMBP, and age. 
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Figure 28: Proposed relevance of findings to previous models of age-related cognitive decline 
Gray boxes indicate steps for which the present study contributed supporting data. 
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Figure 29: Illustration of hypothesized relationships between HA, myelin damage, and remyelination 
impairment 
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